1104 is the total number of securities Perceptive Advisors has owned. The longest Perceptive Advisors has owned a single stock is 42 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
NBIX | NEUROCRINE BIOSCIENCES... | 42 | 42 | 0.27% | 6.43% | 15.71% | Q2 2013 | Q3 2023 | 42 |
FOLD | AMICUS THERAPEUTICS S... | 39 | 39 | 0.21% | 7.48% | 14.03% | Q1 2014 | Q3 2023 | 39 |
ALDX | ALDEYRA THERAPEUTICS ... | 35 | 35 | 0.20% | 0.97% | 3.33% | Q1 2015 | Q3 2023 | 35 |
QTNT | QUOTIENT TECHNOLOGY INC | 34 | 34 | 0.07% | 1.13% | 2.74% | Q2 2014 | Q3 2022 | 34 |
GBT | GLOBAL BLOOD THERAPEUT... | 29 | 29 | 1.56% | 4.81% | 9.26% | Q3 2015 | Q3 2022 | 29 |
ADMA | ADMA BIOLOGICS SHARES | 29 | 29 | 0.08% | 0.65% | 1.38% | Q3 2016 | Q3 2023 | 29 |
RTRX | RETROPHIN SHARES | 28 | 28 | 0.47% | 2.37% | 5.52% | Q4 2013 | Q3 2020 | 28 |
DBVT | DBV TECHNOLOGIES SA-SP... | 28 | 28 | 0.00% | 0.77% | 1.81% | Q4 2014 | Q3 2021 | 28 |
VBIV | VBI VACCINES SHARES | 27 | 27 | 0.47% | 1.40% | 2.76% | Q3 2016 | Q1 2023 | 27 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 26 | 26 | 1.27% | 3.63% | 9.10% | Q2 2017 | Q3 2023 | 26 |
RACE | FERRARI SHARES | 26 | 26 | 0.02% | 0.02% | 0.04% | Q1 2016 | Q2 2022 | 26 |
MRTX | MIRATI THERAPEUTICS INC | 19 | 1 | 0.00% | 4.42% | 8.71% | Q1 2016 | Q2 2023 | 24 |
NVRO | NEVRO SHARES | 13 | 1 | 0.03% | 1.41% | 2.80% | Q4 2014 | Q4 2022 | 24 |
NVTA | INVITAE SHARES | 13 | 5 | 0.09% | 0.75% | 3.27% | Q1 2015 | Q1 2022 | 24 |
EIGR | EIGER BIOPHARMACEUTICA... | 24 | 24 | 0.01% | 0.06% | 0.15% | Q1 2016 | Q4 2021 | 24 |
ALBO | ALBIREO PHARMA INC | 23 | 23 | 0.68% | 1.15% | 1.59% | Q2 2017 | Q4 2022 | 23 |
SRPT | SAREPTA THERAPEUTICS ... | 17 | 5 | 0.27% | 5.17% | 13.46% | Q2 2013 | Q3 2023 | 22 |
MGTX | MEIRAGTX HOLDINGS PLC | 22 | 22 | 1.06% | 1.85% | 3.57% | Q2 2018 | Q3 2023 | 22 |
BPMC | BLUEPRINT MEDICINES S... | 22 | 22 | 0.55% | 1.36% | 2.87% | Q2 2015 | Q3 2020 | 22 |
ZYME | ZYMEWORKS SHARES | 22 | 22 | 0.18% | 1.19% | 3.28% | Q2 2017 | Q3 2022 | 22 |
RGNX | REGENXBIO SHARES | 19 | 3 | 0.03% | 0.99% | 1.85% | Q3 2015 | Q3 2021 | 22 |
CTMX | CYTOMX THERAPEUTICS S... | 19 | 3 | 0.14% | 0.86% | 1.76% | Q4 2015 | Q2 2021 | 22 |
VRCA | VERRICA PHARMACEUTICAL... | 22 | 22 | 0.30% | 0.80% | 1.76% | Q2 2018 | Q3 2023 | 22 |
XENE | XENON PHARMACEUTICALS ... | 11 | 11 | 0.12% | 0.75% | 2.22% | Q4 2014 | Q3 2023 | 22 |
TSRO | TESARO SHARES | 19 | 2 | 0.12% | 3.18% | 6.66% | Q2 2013 | Q3 2018 | 21 |
XNCR | XENCOR SHARES | 21 | 21 | 0.26% | 1.78% | 3.34% | Q4 2013 | Q4 2018 | 21 |
CRNX | CRINETICS PHARMACEUTIC... | 21 | 21 | 0.55% | 1.59% | 3.11% | Q3 2018 | Q3 2023 | 21 |
XLRN | ACCELERON PHARMA SHARES | 19 | 1 | 0.02% | 1.28% | 2.34% | Q2 2014 | Q2 2021 | 21 |
NEPT | NEPTUNE TECHNOLOGIES B... | 21 | 21 | 0.16% | 0.85% | 2.06% | Q2 2013 | Q2 2018 | 21 |
ESTA | ESTABLISHMENT LABS HOL... | 21 | 21 | 0.18% | 0.58% | 0.94% | Q3 2018 | Q3 2023 | 21 |
AGRX | AGILE THERAPEUTICS SH... | 13 | 3 | 0.00% | 0.50% | 3.57% | Q1 2016 | Q1 2022 | 21 |
VERU | VERU INC REGISTERED SHS | 21 | 21 | 0.00% | 0.35% | 1.30% | Q3 2018 | Q3 2023 | 21 |
ATNX | ATHENEX INC | 20 | 20 | 0.06% | 1.38% | 4.31% | Q1 2018 | Q4 2022 | 20 |
MYOK | MYOKARDIA SHARES | 20 | 20 | 0.43% | 1.24% | 2.78% | Q4 2015 | Q3 2020 | 20 |
KDMN | KADMON SHARES | 20 | 20 | 0.62% | 0.97% | 1.72% | Q3 2016 | Q2 2021 | 20 |
RCKT | ROCKET PHARMACUETICALS... | 20 | 20 | 0.13% | 0.79% | 2.00% | Q4 2018 | Q3 2023 | 20 |
CSU | CAPITAL SR LIVING CORP | 16 | 4 | 0.02% | 0.63% | 2.15% | Q2 2013 | Q3 2018 | 20 |
QURE | UNIQURE SHARES | 19 | 19 | 0.23% | 0.80% | 1.96% | Q4 2014 | Q2 2019 | 19 |
ANI PHARMACEUTICALS IN... | 19 | 19 | 0.21% | 0.43% | 0.67% | Q4 2014 | Q2 2019 | 19 | |
ACRX | ACELRX PHARMACEUTICALS... | 18 | 18 | 0.22% | 3.05% | 8.93% | Q2 2013 | Q3 2017 | 18 |
BBIO | BRIDGEBIO PHARMA INC | 18 | 18 | 0.36% | 2.95% | 6.14% | Q2 2019 | Q3 2023 | 18 |
VRTX | VERTEX PHARMACEUTICALS... | 11 | 7 | 0.34% | 1.94% | 7.24% | Q2 2013 | Q2 2018 | 18 |
LJPC | LA JOLLA PHARMACEUTICA... | 18 | 18 | 0.26% | 1.93% | 3.64% | Q3 2014 | Q4 2018 | 18 |
VRNA | VERONA PHARMA PLC | 13 | 5 | 0.01% | 0.79% | 3.58% | Q2 2017 | Q3 2023 | 18 |
ABEO | ABEONA THERAPEUTICS S... | 16 | 2 | 0.02% | 0.21% | 0.57% | Q2 2015 | Q1 2020 | 18 |
ABEOW | ABEONA THERAPEUTICS S... | 18 | 18 | 0.00% | 0.20% | 0.60% | Q2 2015 | Q3 2019 | 18 |
MGCD | MGC DIAGNOSTICS SHARES | 18 | 18 | 0.09% | 0.17% | 0.27% | Q2 2013 | Q3 2017 | 18 |
MOTS | MOTUS GI HOLDINGS INC ... | 18 | 18 | 0.01% | 0.17% | 0.53% | Q1 2018 | Q2 2022 | 18 |
SWTX | SPRINGWORKS THERAPEUTI... | 17 | 17 | 1.17% | 2.97% | 5.19% | Q3 2019 | Q3 2023 | 17 |
CNCE | CONCERT PHARMACEUTICAL... | 16 | 1 | 0.02% | 0.34% | 0.87% | Q3 2015 | Q3 2022 | 17 |
PRTO | PROTEON THERAPEUTICS ... | 16 | 1 | 0.00% | 0.12% | 0.32% | Q4 2014 | Q4 2019 | 17 |
ZGNX | ZOGENIX SHARES | 16 | 16 | 0.01% | 3.48% | 6.01% | Q3 2016 | Q2 2020 | 16 |
VSAR | VERSARTIS SHARES | 16 | 16 | 0.11% | 2.11% | 5.36% | Q1 2014 | Q4 2017 | 16 |
MGNX | MACROGENICS INC | 9 | 7 | 0.11% | 0.66% | 2.36% | Q4 2013 | Q2 2022 | 16 |
AKBA | AKEBIA THERAPEUTICS S... | 15 | 1 | 0.01% | 0.50% | 1.22% | Q3 2015 | Q2 2020 | 16 |
MORF | MORPHIC HOLDING INC | 16 | 16 | 0.18% | 0.39% | 0.75% | Q2 2019 | Q1 2023 | 16 |
ACST | ACASTI PHARMA SHARES ... | 11 | 5 | 0.00% | 0.03% | 0.09% | Q4 2015 | Q4 2019 | 16 |
ACAD | ACADIA PHARMACEUTICALS... | 5 | 1 | 0.01% | 1.02% | 2.92% | Q2 2013 | Q1 2022 | 15 |
ARNA | ARENA PHARMACEUTICALS INC | 14 | 1 | 0.02% | 0.99% | 2.12% | Q4 2017 | Q4 2021 | 15 |
ISEE | IVERIC BIO INC | 15 | 15 | 0.12% | 0.61% | 1.76% | Q4 2019 | Q2 2023 | 15 |
NEPT | NEPTUNE WELLNESS SOLUT... | 15 | 15 | 0.01% | 0.53% | 1.29% | Q3 2018 | Q1 2022 | 15 |
FOMX | FOAMIX PHARMACEUTICALS... | 15 | 15 | 0.15% | 0.47% | 1.04% | Q2 2016 | Q4 2019 | 15 |
CRY | CRYOLIFE SHARES | 8 | 3 | 0.00% | 0.22% | 0.55% | Q3 2016 | Q3 2023 | 15 |
ARWR | ARROWHEAD PHARMACEUTIC... | 8 | 3 | 0.02% | 0.21% | 0.88% | Q3 2016 | Q2 2021 | 15 |
FCAU | FIAT CHRYSLER AUTOMOBI... | 15 | 15 | 0.03% | 0.04% | 0.06% | Q2 2015 | Q4 2018 | 15 |
LYRA | LYRA THERAPEUTICS INC | 14 | 14 | 0.22% | 0.76% | 1.66% | Q2 2020 | Q3 2023 | 14 |
WVE | WAVE LIFE SCIENCES SH... | 12 | 2 | 0.10% | 0.60% | 1.43% | Q1 2016 | Q4 2020 | 14 |
PFNX | PFENEX SHARES | 14 | 14 | 0.05% | 0.57% | 1.18% | Q3 2014 | Q4 2017 | 14 |
EVH | EVOLENT HEALTH SHARES... | 11 | 1 | 0.02% | 0.52% | 1.84% | Q2 2015 | Q1 2022 | 14 |
FPRX | FIVE PRIME THERAPEUTIC... | 14 | 14 | 0.00% | 0.50% | 1.62% | Q4 2013 | Q1 2017 | 14 |
VRAY | VIEWRAY INC REGISTERED... | 14 | 14 | 0.01% | 0.34% | 1.10% | Q4 2017 | Q1 2021 | 14 |
MTEM | MOLECULAR TEMPLATES INC | 14 | 14 | 0.04% | 0.34% | 0.86% | Q3 2017 | Q4 2020 | 14 |
VCEL | VERICEL CORP | 9 | 5 | 0.00% | 0.11% | 0.64% | Q4 2014 | Q1 2019 | 14 |
LBIO | LION BIOTECHNOLOGIES ... | 13 | 13 | 1.24% | 1.91% | 2.98% | Q1 2014 | Q1 2017 | 13 |
KOD | KODIAK SCIENCES INC | 13 | 13 | 0.35% | 1.59% | 5.24% | Q4 2018 | Q4 2021 | 13 |
OM | OUTSET MED INC | 13 | 13 | 0.24% | 1.13% | 2.08% | Q3 2020 | Q3 2023 | 13 |
RLAY | RELAY THERAPEUTICS INC | 13 | 13 | 0.54% | 0.97% | 1.45% | Q3 2020 | Q3 2023 | 13 |
CBAY | CYMABAY THERAPEUTICS INC | 9 | 4 | 0.12% | 0.90% | 2.01% | Q3 2017 | Q3 2023 | 13 |
SLDB | SOLID BIOSCIENCES INC | 10 | 1 | 0.18% | 0.84% | 4.01% | Q4 2018 | Q3 2022 | 13 |
CHRS | COHERUS BIOSCIENCES INC | 10 | 3 | 0.16% | 0.76% | 1.33% | Q4 2014 | Q3 2022 | 13 |
IMTX | IMMATICS N.V | 13 | 13 | 0.29% | 0.64% | 1.35% | Q3 2020 | Q3 2023 | 13 |
ATHA | ATHIRA PHARMA INC | 13 | 13 | 0.32% | 0.59% | 1.14% | Q3 2020 | Q3 2023 | 13 |
XBI | STREETTRACKS SPDR BIOT... | 3 | 1 | 0.00% | 0.52% | 2.28% | Q2 2015 | Q2 2023 | 13 |
PRTA | PROTHENA CORP PLC | 5 | 4 | 0.05% | 0.44% | 1.41% | Q1 2014 | Q3 2023 | 13 |
PRVB | PROVENTION BIO INC | 13 | 13 | 0.01% | 0.39% | 1.04% | Q3 2019 | Q3 2022 | 13 |
AFMD | AFFIMED THERAPEUTICS ... | 7 | 6 | 0.03% | 0.30% | 0.83% | Q3 2014 | Q4 2017 | 13 |
LPTX | LEAP THERAPEUTICS INC | 13 | 13 | 0.07% | 0.25% | 0.49% | Q1 2020 | Q1 2023 | 13 |
IMMU | IMMUNOMEDICS SHARES | 4 | 1 | 0.00% | 0.25% | 1.13% | Q2 2013 | Q3 2020 | 13 |
HCAT | HEALTH CATALYST INC | 13 | 13 | 0.11% | 0.23% | 0.43% | Q3 2019 | Q3 2022 | 13 |
CNC | CENTENE SHARES | 6 | 3 | 0.01% | 0.05% | 0.44% | Q3 2013 | Q4 2017 | 13 |
CAPR | CAPRICOR THERAPEUTICS ... | 9 | 4 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q3 2018 | 13 |
CERE | CEREVEL THERAPEUTICS H... | 12 | 12 | 0.81% | 4.01% | 9.28% | Q4 2020 | Q3 2023 | 12 |
ALNY | ALNYLAM PHARMACEUTICAL... | 9 | 1 | 0.32% | 3.23% | 8.02% | Q1 2014 | Q2 2022 | 12 |
MDGL | MADRIGAL PHARMACEUTICA... | 8 | 4 | 0.01% | 1.39% | 5.97% | Q4 2017 | Q3 2023 | 12 |
RAPT | RAPT THERAPEUTICS INC | 12 | 12 | 0.33% | 1.09% | 1.66% | Q4 2020 | Q3 2023 | 12 |
COGT | COGENT BIOSCIENCES INC | 12 | 12 | 0.34% | 0.67% | 1.39% | Q4 2020 | Q3 2023 | 12 |
ANIP | ANI PHARMACEUTICALS S... | 11 | 1 | 0.04% | 0.60% | 1.50% | Q1 2014 | Q2 2017 | 12 |
HUM | HUMANA SHARES | 8 | 1 | 0.01% | 0.57% | 1.76% | Q1 2014 | Q1 2019 | 12 |
TARS | TARSUS PHARMACEUTICALS... | 12 | 12 | 0.41% | 0.55% | 0.77% | Q4 2020 | Q3 2023 | 12 |
ABMD | ABIOMED SHARES | 5 | 1 | 0.00% | 0.53% | 2.71% | Q1 2014 | Q3 2018 | 12 |
TVTX | TRAVERE THERAPEUTICS INC | 12 | 12 | 0.04% | 0.48% | 1.04% | Q4 2020 | Q3 2023 | 12 |
KRON | KRONOS BIO INC | 12 | 12 | 0.08% | 0.42% | 1.01% | Q4 2020 | Q3 2023 | 12 |
HRMY | HARMONY BIOSCIENCES HL... | 6 | 6 | 0.10% | 0.42% | 1.09% | Q3 2020 | Q3 2023 | 12 |
ANTH | ANTHERA PHARMACEUTICAL... | 9 | 3 | 0.07% | 0.31% | 0.62% | Q3 2013 | Q3 2016 | 12 |
FUSN | FUSION PHARMACEUTICALS... | 9 | 3 | 0.08% | 0.26% | 0.58% | Q2 2020 | Q3 2023 | 12 |
PSDV | PSIVIDA SHARES | 11 | 1 | 0.02% | 0.25% | 0.63% | Q3 2013 | Q2 2017 | 12 |
SRRA | SIERRA ONCOLOGY SHARES | 12 | 12 | 0.02% | 0.21% | 0.62% | Q1 2017 | Q4 2019 | 12 |
STML | STEMLINE THERAPEUTICS INC | 8 | 4 | 0.00% | 0.17% | 1.42% | Q2 2013 | Q4 2016 | 12 |
NBTX | NANOBIOTIX SA | 12 | 12 | 0.11% | 0.15% | 0.20% | Q4 2020 | Q3 2023 | 12 |
MGLN | MAGELLAN HEALTH SVCS INC | 8 | 2 | 0.00% | 0.02% | 0.05% | Q2 2013 | Q4 2016 | 12 |
DYAX | DYAX CORP | 11 | 11 | 0.60% | 2.42% | 5.06% | Q2 2013 | Q4 2015 | 11 |
ZBH | ZIMMER HLDGS INC | 5 | 1 | 0.00% | 0.97% | 2.73% | Q4 2013 | Q1 2020 | 11 |
SRPT | SAREPTA THERAPEUTICS INC | 8 | 1 | 0.01% | 0.95% | 2.83% | Q1 2014 | Q3 2023 | 11 |
GILD | GILEAD SCIENCES INC | 5 | 1 | 0.02% | 0.91% | 4.47% | Q2 2013 | Q1 2020 | 11 |
SGMO | SANGAMO THERAPEUTICS INC | 6 | 1 | 0.00% | 0.64% | 1.52% | Q3 2013 | Q2 2018 | 11 |
ACRS | ACLARIS THERAPEUTICS ... | 8 | 3 | 0.13% | 0.60% | 2.43% | Q3 2016 | Q4 2022 | 11 |
EIDX | EIDOS THERAPEUTICS INC | 11 | 11 | 0.18% | 0.56% | 0.97% | Q2 2018 | Q4 2020 | 11 |
HCA | HCA HOLDINGS INC | 7 | 1 | 0.02% | 0.53% | 1.74% | Q2 2013 | Q3 2016 | 11 |
AGTC | APPLIED GENETIC TECHNO... | 11 | 11 | 0.03% | 0.52% | 1.30% | Q2 2014 | Q4 2016 | 11 |
CLVS | CLOVIS ONCOLOGY SHARES | 7 | 1 | 0.02% | 0.48% | 1.25% | Q2 2013 | Q3 2018 | 11 |
CRBP | CORBUS PHARMACEUTICALS... | 11 | 11 | 0.05% | 0.40% | 1.18% | Q2 2015 | Q4 2017 | 11 |
DSCI | DERMA SCIENCES INC | 11 | 11 | 0.00% | 0.35% | 1.50% | Q1 2014 | Q3 2016 | 11 |
ADPT | ADAPTIVE BIOTECHNOLOGI... | 11 | 11 | 0.15% | 0.30% | 0.59% | Q2 2019 | Q4 2021 | 11 |
ONTY | ONCOTHYREON INC | 11 | 11 | 0.05% | 0.23% | 0.75% | Q3 2013 | Q1 2016 | 11 |
GNVC | GENVEC INC | 11 | 11 | 0.02% | 0.14% | 0.24% | Q1 2014 | Q3 2016 | 11 |
MDGN | MEDGENICS INC | 9 | 2 | 0.03% | 0.12% | 0.40% | Q2 2013 | Q3 2016 | 11 |
WCG | WELLCARE HEALTH PLANS INC | 6 | 1 | 0.00% | 0.10% | 0.76% | Q2 2013 | Q2 2017 | 11 |
CSBR | CHAMPIONS ONCOLOGY SH... | 11 | 11 | 0.04% | 0.07% | 0.16% | Q3 2015 | Q1 2018 | 11 |
TARA | PROTARA THERAPEUTICS INC | 11 | 11 | 0.02% | 0.06% | 0.16% | Q3 2020 | Q1 2023 | 11 |
MCK | MCKESSON SHARES | 6 | 1 | 0.01% | 0.03% | 0.06% | Q2 2014 | Q1 2018 | 11 |
MOH | MOLINA HEALTHCARE INC | 7 | 1 | 0.00% | 0.02% | 0.05% | Q2 2013 | Q2 2017 | 11 |
CELG | CELGENE CORP | 8 | 1 | 0.21% | 2.95% | 10.33% | Q2 2013 | Q4 2016 | 10 |
DOVA | DOVA PHARMACEUTICALS INC | 10 | 10 | 0.78% | 1.72% | 2.79% | Q2 2017 | Q3 2019 | 10 |
INBX | INHIBRX INC | 10 | 10 | 0.32% | 1.44% | 2.72% | Q2 2021 | Q3 2023 | 10 |
EXAS | EXACT SCIENCES SHARES | 5 | 2 | 0.18% | 1.29% | 2.77% | Q2 2013 | Q2 2021 | 10 |
PBYI | PUMA BIOTECHNOLOGY INC | 5 | 1 | 0.01% | 1.17% | 4.22% | Q4 2013 | Q2 2018 | 10 |
TARO | TARO PHARMACEUTICAL IN... | 10 | 10 | 0.01% | 1.06% | 4.15% | Q4 2013 | Q1 2016 | 10 |
ALLO | ALLOGENE THERAPEUTICS INC | 10 | 10 | 0.31% | 0.90% | 1.58% | Q4 2018 | Q1 2021 | 10 |
TMCI | TREACE MEDICAL CONCEPT... | 10 | 10 | 0.28% | 0.86% | 1.82% | Q2 2021 | Q3 2023 | 10 |
NAUT | NAUTILUS BIOTECHNOLOGY... | 10 | 10 | 0.46% | 0.80% | 1.17% | Q2 2021 | Q3 2023 | 10 |
APLS | APELLIS PHARMACEUTICAL... | 6 | 2 | 0.01% | 0.78% | 2.14% | Q1 2020 | Q2 2023 | 10 |
VRDN | VIRIDIAN THERAPEUTICS INC | 10 | 10 | 0.19% | 0.66% | 1.30% | Q2 2021 | Q3 2023 | 10 |
DERM | DERMIRA SHARES | 10 | 10 | 0.16% | 0.63% | 1.28% | Q4 2014 | Q1 2017 | 10 |
AVDL | AVADEL PHARMACEUTICALS... | 6 | 1 | 0.00% | 0.43% | 1.03% | Q4 2016 | Q1 2023 | 10 |
CMAX | CAREMAX INC | 10 | 10 | 0.27% | 0.42% | 0.70% | Q2 2021 | Q3 2023 | 10 |
UROV | UROVANT SCIENCES LTD | 10 | 10 | 0.15% | 0.40% | 0.74% | Q3 2018 | Q4 2020 | 10 |
OMIC | SINGULAR GENOMICS SYST... | 10 | 10 | 0.03% | 0.37% | 1.10% | Q2 2021 | Q3 2023 | 10 |
RYTM | RHYTHM PHARMACEUTICALS... | 7 | 1 | 0.07% | 0.37% | 0.72% | Q4 2017 | Q3 2023 | 10 |
COLL | COLLEGIUM PHARMACEUTIC... | 7 | 1 | 0.02% | 0.36% | 0.66% | Q4 2016 | Q2 2021 | 10 |
INCY | INCYTE SHARES | 5 | 2 | 0.02% | 0.31% | 1.64% | Q4 2013 | Q3 2017 | 10 |
UTHR | UNITED THERAPEUTICS INC | 4 | 1 | 0.02% | 0.29% | 1.44% | Q4 2013 | Q4 2021 | 10 |
NTRA | NATERA INC | 5 | 1 | 0.01% | 0.27% | 1.16% | Q3 2018 | Q3 2023 | 10 |
CBPO | CHINA BIOLOGIC PRODUCT... | 5 | 5 | 0.00% | 0.23% | 1.02% | Q2 2014 | Q1 2017 | 10 |
AET | AETNA INC NEW | 6 | 2 | 0.01% | 0.20% | 1.04% | Q2 2013 | Q3 2016 | 10 |
DRNA | DICERNA PHARMACEUTICAL... | 5 | 1 | 0.02% | 0.15% | 0.39% | Q2 2015 | Q2 2021 | 10 |
FULC | FULCRUM THERAPEUTICS INC | 6 | 4 | 0.04% | 0.12% | 0.26% | Q3 2019 | Q3 2022 | 10 |
TBIO | TRANSLATE BIO INC | 10 | 10 | 0.06% | 0.11% | 0.17% | Q2 2018 | Q3 2020 | 10 |
BCLI | BRAINSTROM CELL THERAP... | 4 | 1 | 0.04% | 0.08% | 0.14% | Q1 2015 | Q1 2018 | 10 |
ICLR | ICON PLC | 5 | 1 | 0.01% | 0.02% | 0.05% | Q2 2014 | Q2 2017 | 10 |
PERNIX THERAPEUTICS HO... | 7 | 3 | 0.01% | 0.02% | 0.02% | Q2 2016 | Q4 2018 | 10 | |
CMAXW | CAREMAX INC | 10 | 10 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2023 | 10 |
RXDX | PROMETHEUS BIOSCIENCES... | 9 | 9 | 0.70% | 2.05% | 4.03% | Q1 2021 | Q1 2023 | 9 |
NUVALENT INC | 9 | 9 | 0.22% | 1.41% | 3.78% | Q3 2021 | Q3 2023 | 9 | |
MMSI | MERIT MED SYS INC | 9 | 9 | 0.16% | 1.24% | 1.99% | Q3 2017 | Q3 2019 | 9 |
ARGX | ARGENX SE-ADR | 7 | 2 | 0.39% | 1.20% | 2.47% | Q2 2017 | Q3 2023 | 9 |
AVXS | AVEXIS SHARES | 9 | 9 | 0.00% | 1.19% | 2.48% | Q1 2016 | Q1 2018 | 9 |
LABP | LANDOS BIOPHARMA INC | 9 | 9 | 0.13% | 1.07% | 3.15% | Q1 2021 | Q1 2023 | 9 |
BIIB | BIOGEN INC | 2 | 1 | 0.02% | 0.84% | 5.02% | Q2 2013 | Q4 2021 | 9 |
EGRX | EAGLE PHARMACEUTICALS INC | 8 | 1 | 0.00% | 0.83% | 2.81% | Q1 2015 | Q2 2017 | 9 |
BMRN | BIOMARIN PHARMACEUTICA... | 5 | 1 | 0.00% | 0.77% | 1.93% | Q3 2016 | Q2 2023 | 9 |
RXDX | IGNYTA SHARES | 8 | 1 | 0.00% | 0.67% | 1.80% | Q2 2015 | Q4 2017 | 9 |
ISRG | INTUITIVE SURGICAL INC | 6 | 1 | 0.01% | 0.67% | 1.25% | Q3 2016 | Q1 2023 | 9 |
IRTC | IRHYTHM TECHNOLOGIES ... | 8 | 1 | 0.42% | 0.64% | 0.79% | Q4 2016 | Q1 2019 | 9 |
MNTA | MOMENTA PHARMACEUTICAL... | 9 | 9 | 0.01% | 0.60% | 1.18% | Q2 2018 | Q2 2020 | 9 |
CEMP | CEMPRA INC | 4 | 1 | 0.00% | 0.60% | 1.53% | Q2 2013 | Q4 2016 | 9 |
ASMB | ASSEMBLY BIOSCIENCES ... | 8 | 1 | 0.16% | 0.56% | 0.96% | Q1 2015 | Q2 2018 | 9 |
CDTX | CIDARA THERAPEUTICS S... | 9 | 9 | 0.02% | 0.54% | 0.94% | Q2 2015 | Q2 2017 | 9 |
SPNC | SPECTRANETICS CORP | 7 | 2 | 0.05% | 0.51% | 1.06% | Q2 2013 | Q1 2016 | 9 |
NERV | MINVERA NEUROSCIENCES | 9 | 9 | 0.28% | 0.46% | 0.74% | Q1 2015 | Q1 2017 | 9 |
ASTRIA THERAPEUTICS INC | 9 | 9 | 0.11% | 0.43% | 0.92% | Q3 2021 | Q3 2023 | 9 | |
CI | CIGNA CORPORATION | 5 | 4 | 0.00% | 0.38% | 1.41% | Q2 2013 | Q4 2015 | 9 |
STOK | STOKE THERAPEUTICS INC | 9 | 9 | 0.26% | 0.36% | 0.45% | Q2 2019 | Q2 2021 | 9 |
RVNC | REVANCE THERAPEUTICS INC | 4 | 2 | 0.03% | 0.33% | 0.63% | Q4 2017 | Q4 2022 | 9 |
CLSD | CLEARSIDE BIOMEDICAL ... | 9 | 9 | 0.14% | 0.31% | 0.71% | Q2 2016 | Q2 2018 | 9 |
NEURODERM LTD | 9 | 9 | 0.09% | 0.31% | 0.45% | Q4 2014 | Q4 2016 | 9 | |
AVEO | AVEO PHARMACEUTICALS ... | 9 | 9 | 0.11% | 0.27% | 0.67% | Q2 2016 | Q2 2018 | 9 |
AXSM | AXSOME THERAPEUTICS INC | 3 | 1 | 0.02% | 0.27% | 1.12% | Q1 2019 | Q3 2023 | 9 |
HNT | HEALTH NET INC | 5 | 4 | 0.02% | 0.25% | 1.18% | Q3 2013 | Q4 2015 | 9 |
CLLS | CELLECTIS SA | 7 | 2 | 0.00% | 0.23% | 0.46% | Q1 2015 | Q1 2018 | 9 |
ACST | ACASTI PHARMA INC | 9 | 9 | 0.03% | 0.19% | 0.63% | Q3 2013 | Q3 2015 | 9 |
SOMALOGIC INC | 9 | 9 | 0.10% | 0.18% | 0.37% | Q3 2021 | Q3 2023 | 9 | |
CSBR | CHAMPIONS ONCOLOGY INC... | 9 | 9 | 0.07% | 0.17% | 0.24% | Q2 2013 | Q2 2015 | 9 |
HSGX | HISTOGENICS CORP | 9 | 9 | 0.02% | 0.17% | 0.37% | Q3 2016 | Q3 2018 | 9 |
TYRA BIOSCIENCES INC | 9 | 9 | 0.11% | 0.16% | 0.25% | Q3 2021 | Q3 2023 | 9 | |
INFI | INFINITY PHARMACEUTICA... | 6 | 3 | 0.01% | 0.14% | 0.58% | Q2 2013 | Q1 2016 | 9 |
CLOV | CLOVER HEALTH INVESTME... | 9 | 9 | 0.04% | 0.11% | 0.26% | Q1 2021 | Q1 2023 | 9 |
VCRA | VOCERA COMMUNICATIONS INC | 6 | 1 | 0.02% | 0.10% | 0.27% | Q1 2014 | Q2 2020 | 9 |
LCI | LANNETT COMPANY INC | 3 | 2 | 0.01% | 0.10% | 0.66% | Q4 2013 | Q3 2016 | 9 |
CRIS | CURIS SHARES | 4 | 1 | 0.01% | 0.10% | 0.45% | Q2 2013 | Q4 2017 | 9 |
AQXP | AQUINOX PHARMACEUTICAL... | 9 | 9 | 0.05% | 0.09% | 0.17% | Q1 2014 | Q1 2016 | 9 |
UNH | UNITEDHEALTH GROUP SH... | 7 | 1 | 0.00% | 0.06% | 0.27% | Q2 2013 | Q2 2017 | 9 |
DARIOHEALTH CORP | 9 | 9 | 0.04% | 0.06% | 0.09% | Q1 2021 | Q1 2023 | 9 | |
GLMD | GALMED PHARMACEUTICALS... | 9 | 9 | 0.03% | 0.05% | 0.09% | Q1 2014 | Q1 2016 | 9 |
AKAOQ | ACHAOGEN SHARES | 5 | 1 | 0.02% | 0.05% | 0.10% | Q1 2014 | Q3 2017 | 9 |
LHCG | LHC GROUP SHARES | 5 | 4 | 0.01% | 0.02% | 0.04% | Q4 2014 | Q2 2017 | 9 |
OTLKW | OUTLOOK THERAPEUTICS INC | 9 | 9 | 0.00% | 0.00% | 0.00% | Q4 2018 | Q4 2020 | 9 |
SURROZEN INC | 9 | 9 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2023 | 9 | |
TRAVERE THERAPEUTICS INC | 8 | 8 | 0.91% | 5.26% | 7.48% | Q1 2020 | Q4 2021 | 8 | |
LIANBIO | 8 | 8 | 2.65% | 3.67% | 5.35% | Q4 2021 | Q3 2023 | 8 | |
COLLEGIUM PHARMACEUTIC... | 8 | 8 | 1.79% | 2.34% | 2.62% | Q2 2020 | Q1 2022 | 8 | |
RLYP | RELYPSA INC | 8 | 8 | 0.57% | 1.97% | 4.08% | Q4 2013 | Q3 2015 | 8 |
ASND | ASCENDIS PHARMA A S | 6 | 2 | 0.01% | 1.63% | 3.70% | Q1 2015 | Q2 2019 | 8 |
PCVX | VAXCYTE INC | 4 | 4 | 0.21% | 1.12% | 2.33% | Q2 2020 | Q3 2023 | 8 |
ANAB | ANAPTYSBIO SHARES | 5 | 1 | 0.18% | 0.98% | 2.52% | Q1 2017 | Q4 2020 | 8 |
CCCC | C4 THERAPEUTICS INC | 8 | 8 | 0.18% | 0.96% | 1.48% | Q4 2020 | Q3 2022 | 8 |
GLPG | GALAPAGOS NV | 7 | 1 | 0.06% | 0.76% | 1.47% | Q2 2015 | Q2 2018 | 8 |
FREQ | FREQUENCY THERAPEUTICS... | 8 | 8 | 0.02% | 0.75% | 1.41% | Q4 2019 | Q3 2021 | 8 |
ARDX | ARDELYX SHARES | 5 | 3 | 0.23% | 0.73% | 1.85% | Q3 2014 | Q3 2017 | 8 |
SHPG | SHIRE PLC | 4 | 1 | 0.17% | 0.69% | 2.08% | Q2 2013 | Q3 2015 | 8 |
ECYT | ENZO BIOCHEM INC | 4 | 4 | 0.09% | 0.61% | 1.16% | Q2 2013 | Q3 2018 | 8 |
ZYNE | ZYNERBA PHARMACEUTICAL... | 7 | 1 | 0.05% | 0.52% | 0.93% | Q3 2015 | Q3 2017 | 8 |
BOLD | AUDENTES THERAPEUTICS ... | 8 | 8 | 0.01% | 0.46% | 0.84% | Q3 2016 | Q2 2018 | 8 |
RAIN | RAIN THERAPEUTICS INC | 8 | 8 | 0.25% | 0.45% | 0.56% | Q2 2021 | Q1 2023 | 8 |
SELB | SELECTA BIOSCIENCES S... | 8 | 8 | 0.12% | 0.38% | 0.81% | Q2 2016 | Q1 2018 | 8 |
TKAI | TOKAI PHARMACEUTICALS INC | 8 | 8 | 0.24% | 0.36% | 0.60% | Q3 2014 | Q2 2016 | 8 |
SAGE | SAGE THERAPEUTICS INC | 6 | 1 | 0.07% | 0.29% | 0.71% | Q3 2014 | Q4 2020 | 8 |
BIO | BIO RAD LABS INC | 5 | 3 | 0.00% | 0.28% | 0.58% | Q3 2016 | Q3 2020 | 8 |
SYBX | SYNLOGIC INC | 8 | 8 | 0.18% | 0.27% | 0.50% | Q3 2017 | Q2 2019 | 8 |
ARNI | ARNO THERAPEUTICS SHARES | 4 | 2 | 0.01% | 0.24% | 0.68% | Q4 2013 | Q2 2017 | 8 |
AXGN | AXOGEN INC | 5 | 1 | 0.00% | 0.23% | 0.39% | Q3 2013 | Q3 2023 | 8 |
ACHN | ACHILLION PHARMACEUTIC... | 4 | 1 | 0.07% | 0.17% | 0.49% | Q2 2014 | Q3 2018 | 8 |
ONEM | 1LIFE HEALTHCARE INC | 8 | 8 | 0.09% | 0.17% | 0.26% | Q1 2020 | Q4 2021 | 8 |
ATEC | ALPHATEC HOLDINGS INC | 5 | 3 | 0.04% | 0.14% | 0.36% | Q3 2019 | Q3 2021 | 8 |
UPI | UROPLASTY INC | 8 | 8 | 0.06% | 0.13% | 0.20% | Q2 2013 | Q1 2015 | 8 |
THC | TENET HEALTHCARE CORP | 4 | 1 | 0.02% | 0.13% | 0.43% | Q3 2014 | Q2 2019 | 8 |
ENVVENO MEDICAL CORPOR... | 8 | 8 | 0.07% | 0.11% | 0.14% | Q4 2021 | Q3 2023 | 8 | |
TXMD | THERAPEUTICSMD SHARES | 2 | 1 | 0.00% | 0.09% | 0.26% | Q1 2014 | Q1 2021 | 8 |
ALNA | ALLENA PHARMACEUTICALS... | 8 | 8 | 0.01% | 0.05% | 0.08% | Q4 2017 | Q3 2019 | 8 |
UHS | UNIVERSAL HLTH SVCS INC | 5 | 3 | 0.01% | 0.03% | 0.04% | Q2 2014 | Q3 2016 | 8 |
CUTR | CUTERA SHARES | 5 | 3 | 0.01% | 0.02% | 0.04% | Q2 2013 | Q1 2018 | 8 |
GTS | TRIPLE-S MGMT CORP | 8 | 8 | 0.01% | 0.02% | 0.02% | Q2 2014 | Q1 2016 | 8 |
EQRX INC | 8 | 8 | 0.00% | 0.00% | 0.01% | Q4 2021 | Q3 2023 | 8 | |
AMYLYX PHARMACEUTICALS... | 7 | 7 | 0.38% | 3.32% | 6.32% | Q1 2022 | Q3 2023 | 7 | |
HZNP | HORIZON THERAPEUTICS P... | 6 | 1 | 2.39% | 2.74% | 3.11% | Q4 2020 | Q4 2022 | 7 |
AMRN | AMARIN CORP PLC-ADR | 6 | 1 | 0.26% | 2.26% | 3.83% | Q3 2016 | Q4 2019 | 7 |
NXTM | NXSTAGE MEDICAL SHARES | 6 | 1 | 0.03% | 2.07% | 3.59% | Q3 2014 | Q3 2017 | 7 |
NEVRO CORP | 7 | 7 | 1.57% | 1.85% | 2.07% | Q2 2020 | Q4 2021 | 7 | |
CORI | CORIUM INTL INC | 7 | 7 | 0.63% | 1.74% | 2.47% | Q1 2017 | Q3 2018 | 7 |
BLU | BELLUS HEALTH INC NEW | 6 | 1 | 0.19% | 1.44% | 3.14% | Q2 2020 | Q1 2023 | 7 |
PTCT | PTC THERAPEUTICS INC | 4 | 3 | 0.02% | 1.42% | 3.17% | Q1 2014 | Q3 2018 | 7 |
IMVT | IMMUNOVANT INC | 4 | 3 | 0.08% | 1.26% | 4.88% | Q2 2020 | Q3 2023 | 7 |
OPHT | OPHTHOTECH SHARES | 5 | 1 | 0.00% | 0.94% | 2.17% | Q4 2013 | Q1 2017 | 7 |
OTIC | OTONOMY INC | 7 | 7 | 0.03% | 0.86% | 2.16% | Q3 2014 | Q1 2016 | 7 |
VAPO | VAPOTHERM INC | 7 | 7 | 0.42% | 0.71% | 0.93% | Q4 2018 | Q2 2020 | 7 |
ARRY | ARRAY BIOPHARMA SHARES | 2 | 1 | 0.01% | 0.62% | 2.91% | Q2 2013 | Q2 2019 | 7 |
NARI | INARI MED INC | 5 | 1 | 0.05% | 0.48% | 0.86% | Q2 2020 | Q3 2022 | 7 |
AERI | ALLIQUA INC | 4 | 3 | 0.13% | 0.48% | 0.99% | Q4 2013 | Q1 2017 | 7 |
BLUE | BLUEBIRD BIO SHARES | 2 | 1 | 0.02% | 0.47% | 1.73% | Q4 2013 | Q4 2017 | 7 |
AXGT | AXOVANT SCIENCES SHARES | 5 | 2 | 0.23% | 0.46% | 0.71% | Q2 2015 | Q2 2017 | 7 |
TRXC | TRANSENTERIX INC | 7 | 7 | 0.30% | 0.44% | 0.64% | Q2 2014 | Q4 2015 | 7 |
ALLIQUA BIOMEDICAL INC | 7 | 7 | 0.14% | 0.38% | 0.61% | Q4 2014 | Q2 2016 | 7 | |
CCXI | CHEMOCENTRYX INC | 5 | 2 | 0.01% | 0.35% | 0.83% | Q1 2020 | Q3 2022 | 7 |
DXCM | DEXCOM INC | 3 | 1 | 0.02% | 0.34% | 1.01% | Q3 2013 | Q2 2019 | 7 |
TDOC | TELADOC INC | 3 | 1 | 0.02% | 0.33% | 0.78% | Q3 2016 | Q2 2019 | 7 |
ALQA | ALLIQUA BIOMEDICAL SH... | 5 | 2 | 0.08% | 0.31% | 0.68% | Q4 2013 | Q3 2017 | 7 |
PTLA | PORTOLA PHARMACEUTICAL... | 3 | 1 | 0.02% | 0.28% | 1.05% | Q4 2014 | Q1 2018 | 7 |
EPZM | EPIZYME SHARES | 4 | 1 | 0.00% | 0.27% | 0.83% | Q2 2013 | Q1 2017 | 7 |
MYL | MYLAN NV | 3 | 2 | 0.02% | 0.26% | 0.88% | Q1 2015 | Q3 2020 | 7 |
NEOS | NEOS THERAPEUTICS INC | 6 | 1 | 0.00% | 0.20% | 0.62% | Q3 2015 | Q4 2017 | 7 |
ACCD | ACCOLADE INC | 7 | 7 | 0.09% | 0.17% | 0.29% | Q3 2020 | Q1 2022 | 7 |
OMED | ONCOMED PHARMACEUTICAL... | 7 | 7 | 0.05% | 0.17% | 0.36% | Q3 2017 | Q1 2019 | 7 |
ATRC | ATRICURE SHARES | 3 | 1 | 0.00% | 0.16% | 0.38% | Q1 2014 | Q3 2020 | 7 |
ARNO THERAPEUTICS INC | 6 | 1 | 0.06% | 0.12% | 0.36% | Q2 2014 | Q2 2016 | 7 | |
KERX | KERYX BIOPHARMACEUTICA... | 2 | 1 | 0.01% | 0.12% | 0.49% | Q2 2013 | Q4 2017 | 7 |
IVC | INVACARE CORP | 6 | 1 | 0.01% | 0.08% | 0.15% | Q3 2016 | Q4 2018 | 7 |
HSAQ | HEALTH SCIENCES ACQ CO... | 7 | 7 | 0.06% | 0.07% | 0.09% | Q3 2020 | Q1 2022 | 7 |
SCYX | SCYNEXIS INC | 7 | 7 | 0.03% | 0.06% | 0.10% | Q2 2015 | Q4 2016 | 7 |
GRTX | GALERA THERAPEUTICS INC | 7 | 7 | 0.03% | 0.05% | 0.08% | Q4 2019 | Q2 2021 | 7 |
AZRX | AZURRX BIOPHARMA SHARES | 7 | 7 | 0.02% | 0.04% | 0.08% | Q4 2016 | Q2 2018 | 7 |
LNTH | LANTHEUS HOLDINGS SHARES | 6 | 1 | 0.01% | 0.03% | 0.05% | Q4 2015 | Q4 2017 | 7 |
HRC | HILL ROM HOLDINGS SHARES | 4 | 1 | 0.00% | 0.02% | 0.04% | Q2 2013 | Q2 2017 | 7 |
SCMP | SUCAMPO PHARMACEUTICAL... | 6 | 1 | 0.00% | 0.02% | 0.03% | Q3 2015 | Q4 2017 | 7 |
AMSG | AMSURG CORP | 2 | 1 | 0.00% | 0.01% | 0.03% | Q2 2013 | Q3 2016 | 7 |
ARCELLX INC | 6 | 6 | 0.65% | 2.69% | 4.75% | Q2 2022 | Q3 2023 | 6 | |
SOLID BIOSCIENCES INC | 3 | 1 | 0.42% | 1.91% | 4.95% | Q1 2018 | Q1 2020 | 6 | |
RCPT | RECEPTOS INC | 6 | 6 | 0.15% | 1.39% | 2.99% | Q1 2014 | Q2 2015 | 6 |
INSM | INSMED INC | 6 | 6 | 0.42% | 1.22% | 3.53% | Q1 2014 | Q2 2015 | 6 |
HRTX | HERON THERAPEUTICS INC | 4 | 1 | 0.20% | 1.16% | 2.58% | Q1 2014 | Q3 2017 | 6 |
AKRO | AKERO THERAPEUTICS INC | 5 | 1 | 0.01% | 1.15% | 2.73% | Q3 2020 | Q3 2023 | 6 |
MYL | MYLAN INC | 6 | 6 | 0.24% | 1.12% | 2.05% | Q3 2013 | Q4 2014 | 6 |
BHVN | BIOHAVEN PHARMACTL HLD... | 6 | 6 | 0.15% | 1.11% | 2.84% | Q2 2017 | Q3 2018 | 6 |
RDUS | RADIUS HEALTH SHARES | 4 | 2 | 0.24% | 1.08% | 2.00% | Q1 2015 | Q2 2017 | 6 |
REGN | REGENERON PHARMACEUTIC... | 4 | 1 | 0.04% | 0.82% | 3.16% | Q2 2013 | Q4 2020 | 6 |
COHERUS BIOSCIENCES INC | 6 | 6 | 0.10% | 0.67% | 0.92% | Q2 2021 | Q3 2022 | 6 | |
VBIV | VBI VACCINES INC. | 6 | 6 | 0.41% | 0.62% | 0.84% | Q1 2015 | Q2 2016 | 6 |
PROCEPT BIOROBOTICS CORP | 6 | 6 | 0.08% | 0.61% | 1.04% | Q3 2021 | Q4 2022 | 6 | |
TPTX | TURNING POINT THERAPEU... | 6 | 6 | 0.34% | 0.45% | 0.60% | Q2 2019 | Q3 2020 | 6 |
ZLTQ | ZELTIQ AESTHETICS INC | 4 | 2 | 0.01% | 0.42% | 1.21% | Q3 2013 | Q2 2016 | 6 |
ATRS | ANTARES PHARMA SHARES | 6 | 6 | 0.06% | 0.42% | 0.69% | Q3 2016 | Q4 2017 | 6 |
EHTH | EHEALTH INC | 6 | 6 | 0.08% | 0.39% | 0.76% | Q3 2018 | Q4 2019 | 6 |
RNA | AVIDITY BIOSCIENCES INC | 6 | 6 | 0.30% | 0.39% | 0.51% | Q2 2020 | Q3 2021 | 6 |
FWP | FORWARD PHARMA A/S-ADR | 6 | 6 | 0.20% | 0.38% | 0.55% | Q1 2016 | Q2 2017 | 6 |
RVMD | REVOLUTION MEDICINES INC | 4 | 1 | 0.10% | 0.33% | 1.22% | Q1 2020 | Q3 2023 | 6 |
NUVB | NUVATION BIO INC | 6 | 6 | 0.18% | 0.32% | 0.44% | Q1 2021 | Q2 2022 | 6 |
PMVP | PMV PHARMACEUTICALS INC | 6 | 6 | 0.04% | 0.29% | 0.58% | Q3 2020 | Q4 2021 | 6 |
YMAB | Y-MABS THERAPEUTICS INC | 4 | 2 | 0.09% | 0.28% | 0.60% | Q3 2019 | Q3 2022 | 6 |
AQUESTIVE THERAPEUTICS... | 6 | 6 | 0.10% | 0.28% | 0.51% | Q4 2018 | Q1 2020 | 6 | |
AXNX | AXONICS MODULATION TEC... | 3 | 1 | 0.03% | 0.27% | 0.46% | Q4 2018 | Q1 2022 | 6 |
SILK | SILK ROAD MEDICAL INC | 6 | 6 | 0.09% | 0.26% | 0.51% | Q1 2020 | Q2 2021 | 6 |
ONCR | ONCORUS INC | 6 | 6 | 0.03% | 0.26% | 0.69% | Q4 2020 | Q1 2022 | 6 |
ELGX | ENDOLOGIX INC | 6 | 6 | 0.01% | 0.26% | 0.75% | Q4 2014 | Q1 2016 | 6 |
ALEC | ALECTOR INC | 6 | 6 | 0.18% | 0.23% | 0.32% | Q1 2019 | Q2 2020 | 6 |
CPRX | CATALYST PHARM PARTNER... | 5 | 1 | 0.01% | 0.23% | 0.40% | Q2 2014 | Q1 2016 | 6 |
ILMN | ILLUMINA SHARES | 2 | 1 | 0.03% | 0.21% | 0.79% | Q4 2013 | Q2 2023 | 6 |
SCPEU | SC HEALTH CORP | 6 | 6 | 0.12% | 0.20% | 0.28% | Q3 2019 | Q4 2020 | 6 |
WBA | WALGREENS BOOTS ALLIAN... | 6 | 6 | 0.13% | 0.19% | 0.26% | Q4 2014 | Q1 2016 | 6 |
SUPN | SUPERNUS PHARMACEUTICA... | 4 | 1 | 0.00% | 0.17% | 0.39% | Q4 2014 | Q4 2016 | 6 |
RGEN | REPLIGEN CORP | 3 | 1 | 0.06% | 0.17% | 0.27% | Q3 2013 | Q3 2015 | 6 |
VNDA | VANDA PHARMACEUTICALS ... | 3 | 1 | 0.02% | 0.16% | 0.78% | Q3 2013 | Q3 2017 | 6 |
BLSA | BCLS ACQUISITION CORP | 6 | 6 | 0.12% | 0.15% | 0.20% | Q4 2020 | Q1 2022 | 6 |
PNT | POINT BIOPHARMA GLOBAL... | 6 | 6 | 0.10% | 0.15% | 0.23% | Q3 2021 | Q4 2022 | 6 |
TWST | TWIST BIOSCIENCE CORP | 6 | 6 | 0.07% | 0.14% | 0.27% | Q2 2019 | Q3 2020 | 6 |
AGEN | AGENUS SHARES | 3 | 1 | 0.00% | 0.12% | 0.42% | Q1 2014 | Q1 2017 | 6 |
PSTX | POSEIDA THERAPEUTICS INC | 5 | 1 | 0.08% | 0.09% | 0.10% | Q3 2020 | Q3 2022 | 6 |
BGNE | BEIGENE LTD | 5 | 1 | 0.02% | 0.06% | 0.26% | Q3 2016 | Q3 2018 | 6 |
NVLS | NIVALIS THERAPEUTICS INC | 6 | 6 | 0.02% | 0.06% | 0.13% | Q3 2015 | Q4 2016 | 6 |
MREO | MEREO BIOPHARMA GROUP PLC | 4 | 2 | 0.01% | 0.06% | 0.26% | Q2 2019 | Q2 2021 | 6 |
CGNT | COGENTIX MED INC | 6 | 6 | 0.01% | 0.05% | 0.07% | Q2 2015 | Q3 2016 | 6 |
PEAR THERAPEUTICS INC | 6 | 6 | 0.01% | 0.05% | 0.09% | Q4 2021 | Q1 2023 | 6 | |
INCR | INC RESH HLDGS INC | 2 | 1 | 0.02% | 0.03% | 0.05% | Q2 2015 | Q2 2017 | 6 |
TRILLIUM THERAPEUTICS INC | 4 | 2 | 0.02% | 0.03% | 0.04% | Q2 2015 | Q3 2020 | 6 | |
PAHC | PHIBRO ANIMAL HEALTH ... | 3 | 1 | 0.02% | 0.03% | 0.04% | Q4 2014 | Q1 2017 | 6 |
BVX | BOVIE MEDICAL CORP | 5 | 1 | 0.02% | 0.03% | 0.04% | Q1 2015 | Q3 2016 | 6 |
CAH | CARDINAL HEALTH INC | 3 | 3 | 0.01% | 0.03% | 0.04% | Q1 2015 | Q3 2016 | 6 |
CRL | CHARLES RIV LABS INTL INC | 4 | 2 | 0.01% | 0.02% | 0.04% | Q2 2014 | Q3 2016 | 6 |
CBM | CAMBREX SHARES | 5 | 1 | 0.02% | 0.02% | 0.03% | Q4 2014 | Q1 2017 | 6 |
SRRA | SIERRA ONCOLOGY INC | 6 | 6 | 0.01% | 0.01% | 0.02% | Q1 2020 | Q2 2021 | 6 |
ONSIW | ONCOBIOLOGICS INC WTS | 5 | 1 | 0.00% | 0.01% | 0.02% | Q2 2016 | Q3 2018 | 6 |
PPHM | PEREGRINE PHARMACEUTIC... | 6 | 6 | 0.00% | 0.00% | 0.01% | Q1 2016 | Q2 2017 | 6 |
AEGR | AEGERION PHARMACEUTICA... | 3 | 1 | 0.78% | 9.03% | 22.82% | Q2 2013 | Q1 2015 | 5 |
RETA | REATA PHARMACEUTICALS INC | 2 | 1 | 0.02% | 1.58% | 5.82% | Q3 2018 | Q2 2023 | 5 |
WAG | WALGREEN CO | 5 | 5 | 0.32% | 1.51% | 2.22% | Q3 2013 | Q3 2014 | 5 |
F113PS | COVIDIEN PLC | 5 | 5 | 0.22% | 1.36% | 3.07% | Q2 2013 | Q2 2014 | 5 |
FLML | FLAMEL TECHNOLOGIES -S... | 4 | 1 | 0.31% | 0.93% | 1.18% | Q1 2014 | Q3 2016 | 5 |
MDT | MEDTRONIC PLC | 2 | 1 | 0.03% | 0.70% | 1.53% | Q1 2015 | Q3 2023 | 5 |
THOR | THORATEC CORP | 5 | 5 | 0.42% | 0.70% | 1.07% | Q3 2014 | Q3 2015 | 5 |
BIIB | BIOGEN INC | 2 | 1 | 0.00% | 0.62% | 2.65% | Q1 2018 | Q1 2021 | 5 |
ZNTL | ZENTALIS PHARMACEUTICA... | 3 | 2 | 0.46% | 0.57% | 0.74% | Q2 2020 | Q1 2022 | 5 |
PROTAGONIST THERAPEUTI... | 5 | 5 | 0.29% | 0.52% | 0.74% | Q3 2018 | Q3 2019 | 5 | |
ASSEMBLY BIOSCIENCES INC | 5 | 5 | 0.31% | 0.52% | 0.91% | Q2 2015 | Q2 2016 | 5 | |
BDSI | BIODELIVERY SCIENCES I... | 4 | 1 | 0.17% | 0.47% | 0.83% | Q2 2013 | Q4 2014 | 5 |
DICE THERAPEUTICS INC | 5 | 5 | 0.26% | 0.41% | 0.58% | Q4 2021 | Q4 2022 | 5 | |
ICOSAVAX INC | 5 | 5 | 0.01% | 0.38% | 0.83% | Q3 2021 | Q3 2022 | 5 | |
ATHX | ATHERSYS INC | 5 | 5 | 0.11% | 0.35% | 0.58% | Q2 2013 | Q2 2014 | 5 |
ARDELYX INC | 5 | 5 | 0.19% | 0.31% | 0.44% | Q2 2015 | Q2 2016 | 5 | |
ISOPLEXIS CORP | 5 | 5 | 0.18% | 0.30% | 0.58% | Q4 2021 | Q4 2022 | 5 | |
PRQR | PROQR THRAPEUTICS N V | 3 | 2 | 0.18% | 0.29% | 0.43% | Q3 2014 | Q1 2019 | 5 |
BCRX | BIOCRYST PHARMACEUTICALS | 2 | 1 | 0.11% | 0.29% | 0.60% | Q3 2013 | Q4 2016 | 5 |
MEIP | MEI PHARMA INC | 4 | 1 | 0.13% | 0.28% | 0.44% | Q4 2018 | Q1 2020 | 5 |
ZY | ZYMERGEN INC | 5 | 5 | 0.03% | 0.23% | 0.85% | Q2 2021 | Q2 2022 | 5 |
ONS | ONCOBIOLOGICS SHARES | 5 | 5 | 0.04% | 0.23% | 0.34% | Q2 2016 | Q2 2017 | 5 |
GERN | GERON CORP | 3 | 1 | 0.00% | 0.23% | 0.48% | Q4 2013 | Q4 2020 | 5 |
ESPR | ESPERION THERAPEUTICS ... | 3 | 2 | 0.00% | 0.22% | 1.03% | Q4 2014 | Q1 2018 | 5 |
MRNS | MARINUS PHARMACEUTICAL... | 5 | 5 | 0.10% | 0.22% | 0.33% | Q3 2017 | Q3 2018 | 5 |
DAWN | DAY ONE BIOPHARMACEUTI... | 5 | 5 | 0.11% | 0.20% | 0.31% | Q2 2021 | Q2 2022 | 5 |
VTRS | VIATRIS INC | 5 | 5 | 0.18% | 0.19% | 0.21% | Q4 2020 | Q4 2021 | 5 |
SEMA4 HOLDINGS CORP | 5 | 5 | 0.13% | 0.19% | 0.28% | Q3 2021 | Q3 2022 | 5 | |
CDNA | CAREDX INC | 5 | 5 | 0.04% | 0.18% | 0.25% | Q4 2017 | Q4 2018 | 5 |
ICPT | INTERCEPT PHARMACEUTIC... | 3 | 1 | 0.02% | 0.16% | 0.24% | Q3 2017 | Q4 2019 | 5 |
ABSCI CORPORATION | 5 | 5 | 0.08% | 0.16% | 0.25% | Q3 2021 | Q3 2022 | 5 | |
RACB | RESEARCH ALLIANCE CORP II | 5 | 5 | 0.13% | 0.15% | 0.20% | Q1 2021 | Q1 2022 | 5 |
DRRX | DURECT CORP | 5 | 5 | 0.06% | 0.13% | 0.16% | Q1 2014 | Q1 2015 | 5 |
LEGN | LEGEND BIOTECH CORP | 3 | 2 | 0.01% | 0.12% | 0.45% | Q2 2020 | Q1 2022 | 5 |
SGYPQ | SYNERGY PHARMACEUTICAL... | 3 | 1 | 0.01% | 0.12% | 0.26% | Q3 2015 | Q1 2018 | 5 |
TSHA | TAYSHA GENE THERAPIES INC | 5 | 5 | 0.09% | 0.12% | 0.15% | Q3 2020 | Q3 2021 | 5 |
SNSS | SUNESIS PHARMACEUTICAL... | 4 | 1 | 0.03% | 0.09% | 0.13% | Q2 2013 | Q3 2015 | 5 |
TNDM | TANDEM DIABETES CARE INC | 5 | 5 | 0.01% | 0.09% | 0.37% | Q4 2018 | Q4 2019 | 5 |
ARIA | ARIAD PHARMACEUTICALS INC | 4 | 1 | 0.00% | 0.07% | 0.21% | Q1 2015 | Q4 2016 | 5 |
ALR | ALERE INC | 4 | 1 | 0.00% | 0.07% | 0.31% | Q2 2013 | Q4 2014 | 5 |
OXGN | OXIGENE INC | 5 | 5 | 0.01% | 0.07% | 0.20% | Q1 2014 | Q1 2015 | 5 |
EXEL | EXELIXIS SHARES INC | 5 | 5 | 0.04% | 0.05% | 0.06% | Q4 2016 | Q4 2017 | 5 |
TBIO | TRANSGENOMIC INC | 5 | 5 | 0.00% | 0.05% | 0.09% | Q1 2014 | Q1 2015 | 5 |
PHR | PHREESIA INC | 3 | 2 | 0.03% | 0.05% | 0.07% | Q4 2019 | Q1 2021 | 5 |
STEM | STEMCELLS INC | 5 | 5 | 0.03% | 0.04% | 0.05% | Q2 2013 | Q2 2014 | 5 |
SCAI | SURGICAL CARE AFFILIAT... | 2 | 1 | 0.02% | 0.03% | 0.08% | Q4 2013 | Q4 2015 | 5 |
AGLE | AEGLEA BIOTHERAPEUTICS... | 4 | 1 | 0.00% | 0.02% | 0.04% | Q2 2016 | Q2 2018 | 5 |
MACK | MERRIMACK PHARMACEUTIC... | 5 | 5 | 0.01% | 0.02% | 0.04% | Q4 2015 | Q4 2016 | 5 |
ONSIZ | ONCOBIOLOGICS INC WTS | 5 | 5 | 0.00% | 0.02% | 0.05% | Q2 2016 | Q2 2017 | 5 |
ALQA | ALLIQUA BIOMEDICAL INC | 5 | 5 | 0.01% | 0.02% | 0.03% | Q4 2017 | Q4 2018 | 5 |
WOOF | VCA INC | 2 | 1 | 0.00% | 0.02% | 0.04% | Q2 2013 | Q3 2016 | 5 |
SURROZEN INC | 5 | 5 | 0.00% | 0.02% | 0.05% | Q3 2021 | Q3 2022 | 5 | |
PMC | PHARMERICA CORP | 4 | 1 | 0.01% | 0.02% | 0.03% | Q2 2014 | Q1 2016 | 5 |
MRGE | MERGE HEALTHCARE INC | 5 | 5 | 0.01% | 0.02% | 0.03% | Q2 2014 | Q2 2015 | 5 |
GB | GREATBATCH INC | 4 | 1 | 0.01% | 0.02% | 0.02% | Q3 2014 | Q4 2015 | 5 |
EXAC | EXACTECH INC | 4 | 1 | 0.01% | 0.01% | 0.02% | Q2 2014 | Q4 2015 | 5 |
SENS | SENSEONICS HOLDINGS INC | 5 | 5 | 0.01% | 0.01% | 0.02% | Q3 2017 | Q3 2018 | 5 |
BFLYWS | BUTTERFLY NETWORK INC | 5 | 5 | 0.01% | 0.01% | 0.02% | Q1 2021 | Q1 2022 | 5 |
HCM | HUTCHISON CHINA MEDITE... | 5 | 5 | 0.01% | 0.01% | 0.01% | Q3 2017 | Q3 2018 | 5 |
MOTUS GI HLDGS INC | 5 | 5 | 0.00% | 0.00% | 0.01% | Q3 2022 | Q3 2023 | 5 | |
ONCS | ONCOSEC MED INC | 5 | 5 | 0.00% | 0.00% | 0.00% | Q1 2018 | Q1 2019 | 5 |
INGN | INOGEN INC | 5 | 5 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q4 2016 | 5 |
FLKS | FLEX PHARMA INC | 5 | 5 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q4 2016 | 5 |
SRPT | SAREPTA THERAPEUTICS I... | 1 | 1 | 0.02% | 2.99% | 10.07% | Q4 2013 | Q4 2016 | 4 |
CINCOR PHARMA INC | 4 | 4 | 0.82% | 1.56% | 3.15% | Q1 2022 | Q4 2022 | 4 | |
QCOR | QUESTCOR PHARMACEUTICA... | 2 | 2 | 0.19% | 1.45% | 3.63% | Q2 2013 | Q2 2014 | 4 |
AVIR | ATEA PHARMACEUTICALS INC | 4 | 4 | 0.63% | 1.38% | 2.34% | Q4 2020 | Q3 2021 | 4 |
MDVN | MEDIVATION INC | 2 | 1 | 0.22% | 1.25% | 3.18% | Q3 2013 | Q2 2016 | 4 |
TEVA | TEVA PHARMACEUTICAL IN... | 4 | 4 | 0.68% | 1.24% | 2.34% | Q3 2015 | Q2 2016 | 4 |
ACRIVON THERAPEUTICS INC | 4 | 4 | 0.96% | 1.05% | 1.13% | Q4 2022 | Q3 2023 | 4 | |
RPRX | REPROS THERAPEUTICS INC | 3 | 1 | 0.13% | 0.97% | 3.27% | Q2 2013 | Q3 2015 | 4 |
CHTP | CHELSEA THERAPEUTICS I... | 4 | 4 | 0.76% | 0.90% | 1.08% | Q2 2013 | Q1 2014 | 4 |
ANAC | ANACOR PHARMACEUTICALS... | 2 | 2 | 0.33% | 0.86% | 1.36% | Q2 2013 | Q2 2014 | 4 |
ROIVANT SCIENCES LTD | 4 | 4 | 0.44% | 0.86% | 1.49% | Q4 2022 | Q3 2023 | 4 | |
DEPO | DEPOMED INC | 4 | 4 | 0.67% | 0.79% | 0.86% | Q4 2015 | Q3 2016 | 4 |
MNLO | MENLO THERAPEUTICS INC | 2 | 2 | 0.26% | 0.76% | 1.68% | Q1 2018 | Q2 2020 | 4 |
AGIO | AGIOS PHARMACEUTICALS INC | 3 | 1 | 0.57% | 0.76% | 0.85% | Q1 2018 | Q2 2020 | 4 |
ACADIA PHARMACEUTICALS... | 3 | 1 | 0.37% | 0.71% | 1.04% | Q2 2015 | Q2 2016 | 4 | |
ZYMEWORKS INC | 4 | 4 | 0.31% | 0.70% | 1.00% | Q4 2022 | Q3 2023 | 4 | |
FMTX | FORMA THERAPEUTICS HOL... | 4 | 4 | 0.44% | 0.69% | 0.94% | Q2 2020 | Q1 2021 | 4 |
ABBV | ABBVIE SHARES | 2 | 1 | 0.00% | 0.65% | 2.22% | Q4 2013 | Q1 2017 | 4 |
ITMN | INTERMUNE INC | 2 | 2 | 0.29% | 0.62% | 0.91% | Q2 2013 | Q2 2014 | 4 |
PTGX | PROTAGONIST THERAPEUTI... | 3 | 1 | 0.04% | 0.62% | 1.18% | Q4 2020 | Q3 2023 | 4 |
ONCE | SPARK THERAPEUTICS INC | 2 | 1 | 0.09% | 0.61% | 0.91% | Q1 2015 | Q3 2019 | 4 |
ALDR | ALDER BIOPHARMACEUTICA... | 3 | 1 | 0.34% | 0.55% | 0.83% | Q1 2015 | Q1 2017 | 4 |
B108PS | ACTAVIS PLC | 3 | 1 | 0.02% | 0.47% | 1.14% | Q1 2014 | Q1 2015 | 4 |
SOLID BIOSCIENCES INC | 4 | 4 | 0.29% | 0.46% | 0.53% | Q4 2022 | Q3 2023 | 4 | |
MRKR | MARKER THERAPEUTICS INC | 4 | 4 | 0.28% | 0.36% | 0.42% | Q4 2018 | Q3 2019 | 4 |
CABA | CABALETTA BIO INC | 4 | 4 | 0.08% | 0.35% | 0.58% | Q4 2022 | Q3 2023 | 4 |
THOR | THORATEC CORP | 4 | 4 | 0.27% | 0.34% | 0.51% | Q4 2014 | Q3 2015 | 4 |
CMRX | CHIMERIX INC | 4 | 4 | 0.27% | 0.33% | 0.38% | Q4 2013 | Q3 2014 | 4 |
ADHD | ALCOBRA SHARES | 3 | 1 | 0.00% | 0.29% | 0.48% | Q4 2015 | Q1 2017 | 4 |
VNDA | VANDA PHARMACEUTICALS INC | 3 | 1 | 0.07% | 0.26% | 0.78% | Q3 2013 | Q1 2015 | 4 |
HILLEVAX INC | 4 | 4 | 0.19% | 0.26% | 0.38% | Q2 2022 | Q1 2023 | 4 | |
VYNE | VYNE THERAPEUTICS INC | 4 | 4 | 0.03% | 0.23% | 0.59% | Q1 2021 | Q4 2021 | 4 |
ORTX | ORCHARD THERAPEUTICS PLC | 4 | 4 | 0.17% | 0.23% | 0.31% | Q4 2018 | Q3 2019 | 4 |
AQST | AQUESTIVE THERAPEUTICS... | 3 | 1 | 0.08% | 0.22% | 0.54% | Q3 2018 | Q4 2020 | 4 |
RACA | THERAPEUTICS ACQUISITI... | 4 | 4 | 0.10% | 0.21% | 0.32% | Q3 2020 | Q2 2021 | 4 |
PODD | INSULET CORP | 3 | 1 | 0.13% | 0.21% | 0.36% | Q1 2020 | Q3 2021 | 4 |
IMCR | IMMUNOCORE HLDGS PLC | 4 | 4 | 0.19% | 0.21% | 0.22% | Q1 2021 | Q4 2021 | 4 |
IDYA | IDEAYA BIOSCIENCES INC | 4 | 4 | 0.12% | 0.20% | 0.26% | Q2 2019 | Q1 2020 | 4 |
AMAG | AMAG PHARMACEUTICALS ... | 3 | 1 | 0.01% | 0.20% | 0.72% | Q3 2015 | Q1 2017 | 4 |
FBRX | FORTE BIOSCIENCES INC | 3 | 1 | 0.07% | 0.20% | 0.30% | Q4 2020 | Q3 2023 | 4 |
NANOSTRING TECHNOLOGIE... | 4 | 4 | 0.18% | 0.20% | 0.22% | Q2 2021 | Q1 2022 | 4 | |
VIVE | VIVEVE MED INC | 3 | 1 | 0.03% | 0.20% | 0.34% | Q1 2017 | Q1 2018 | 4 |
CLDX | CELLDEX THERAPEUTICS I... | 3 | 1 | 0.01% | 0.20% | 0.32% | Q3 2020 | Q4 2021 | 4 |
FDMT | 4D MOLECULAR THERAPEUT... | 4 | 4 | 0.12% | 0.19% | 0.27% | Q4 2020 | Q3 2021 | 4 |
HEWG | ISHARES TR | 4 | 4 | 0.14% | 0.19% | 0.26% | Q1 2015 | Q4 2015 | 4 |
GRPH | GRAPHITE BIO INC | 4 | 4 | 0.03% | 0.19% | 0.35% | Q2 2021 | Q1 2022 | 4 |
TNDM | TANDEM DIABETES CARE INC | 2 | 2 | 0.02% | 0.17% | 0.39% | Q4 2013 | Q1 2016 | 4 |
PYXIS ONCOLOGY INC | 4 | 4 | 0.09% | 0.16% | 0.33% | Q4 2021 | Q3 2022 | 4 | |
NVO | NOVO-NORDISK A S | 4 | 4 | 0.01% | 0.16% | 0.56% | Q2 2015 | Q1 2016 | 4 |
SMIHU | SUMMIT HEALTHCRE ACQUI... | 4 | 4 | 0.13% | 0.16% | 0.20% | Q2 2021 | Q1 2022 | 4 |
SCIENCE 37 HOLDINGS INC | 4 | 4 | 0.07% | 0.15% | 0.29% | Q4 2021 | Q3 2022 | 4 | |
ELOS | SYNERON MEDICAL LTD | 4 | 4 | 0.12% | 0.14% | 0.17% | Q1 2014 | Q4 2014 | 4 |
SAVA | CASSAVA SCIENCES INC | 2 | 1 | 0.09% | 0.13% | 0.20% | Q3 2021 | Q4 2022 | 4 |
PRVA | PRIVIA HEALTH GROUP INC | 2 | 1 | 0.06% | 0.12% | 0.25% | Q2 2021 | Q4 2022 | 4 |
AMWL | AMERICAN WELL CORP | 4 | 4 | 0.05% | 0.12% | 0.20% | Q3 2020 | Q2 2021 | 4 |
ACHL | ACHILLES THERAPEUTICS PLC | 4 | 4 | 0.06% | 0.10% | 0.16% | Q1 2021 | Q4 2021 | 4 |
MCRB | SERES THERAPEUTICS INC | 1 | 1 | 0.00% | 0.10% | 0.18% | Q2 2015 | Q2 2019 | 4 |
MRUS | MERUS NV | 2 | 2 | 0.05% | 0.09% | 0.17% | Q1 2021 | Q1 2022 | 4 |
HYPERFINE INC | 4 | 4 | 0.02% | 0.09% | 0.17% | Q4 2021 | Q3 2022 | 4 | |
ODT | ODONATE THERAPEUTICS INC | 4 | 4 | 0.05% | 0.09% | 0.12% | Q4 2017 | Q3 2018 | 4 |
TCRR | TCR2 THERAPEUTICS INC | 4 | 4 | 0.01% | 0.09% | 0.13% | Q3 2020 | Q2 2021 | 4 |
PARNF | PARNELL PHARMACEUT HLD... | 4 | 4 | 0.02% | 0.08% | 0.13% | Q3 2014 | Q2 2015 | 4 |
ABOS | ACUMEN PHARMACEUTICALS... | 4 | 4 | 0.05% | 0.07% | 0.12% | Q1 2022 | Q4 2022 | 4 |
BCTG | BCTG ACQUISITION CORP | 4 | 4 | 0.06% | 0.07% | 0.08% | Q3 2020 | Q2 2021 | 4 |
ENZ | ENZO BIOCHEM INC | 3 | 1 | 0.02% | 0.06% | 0.17% | Q1 2014 | Q4 2016 | 4 |
PGNX | PROGENICS PHARMACEUTIC... | 2 | 2 | 0.01% | 0.06% | 0.14% | Q2 2013 | Q1 2018 | 4 |
AVINGER INC | 3 | 1 | 0.00% | 0.06% | 0.12% | Q2 2015 | Q2 2016 | 4 | |
TCON | TRACON PHARMACEUTICALS... | 2 | 2 | 0.00% | 0.06% | 0.11% | Q1 2015 | Q1 2017 | 4 |
SONENDO INC | 4 | 4 | 0.02% | 0.04% | 0.06% | Q4 2021 | Q3 2022 | 4 | |
LSAQ | LIFESCI ACQUISITION II... | 4 | 4 | 0.03% | 0.04% | 0.04% | Q4 2020 | Q3 2021 | 4 |
ADAP | ADAPTIMMUNE THERAPEUTI... | 3 | 1 | 0.02% | 0.04% | 0.06% | Q2 2018 | Q4 2020 | 4 |
XIV | CREDIT SUISSE VELOCITY... | 3 | 1 | 0.00% | 0.04% | 0.09% | Q2 2015 | Q1 2017 | 4 |
AMN | AMN HEALTHCARE SERVICE... | 2 | 1 | 0.01% | 0.03% | 0.05% | Q3 2014 | Q4 2016 | 4 |
ZSAN | ZOSANO PHARMA SHARES | 4 | 4 | 0.01% | 0.03% | 0.05% | Q1 2017 | Q4 2017 | 4 |
ANTHEM INC | 2 | 2 | 0.01% | 0.03% | 0.05% | Q2 2015 | Q2 2016 | 4 | |
Q | QUINTILES TRANSNATIO H... | 2 | 1 | 0.01% | 0.02% | 0.04% | Q2 2014 | Q3 2016 | 4 |
ENTA | ENANTA PHARMACEUTICALS... | 1 | 1 | 0.01% | 0.02% | 0.04% | Q3 2014 | Q1 2018 | 4 |
VYGR | VOYAGER THERAPEUTICS INC | 2 | 1 | 0.00% | 0.02% | 0.03% | Q2 2016 | Q2 2019 | 4 |
RAD | RITE AID CORP | 2 | 2 | 0.01% | 0.02% | 0.03% | Q4 2013 | Q1 2015 | 4 |
LPNT | LIFEPOINT HOSPITALS INC | 2 | 1 | 0.01% | 0.01% | 0.02% | Q3 2013 | Q4 2015 | 4 |
FLDM | FLUIDIGM CORP DEL | 2 | 2 | 0.01% | 0.01% | 0.02% | Q4 2013 | Q2 2019 | 4 |
CYH | COMMUNITY HEALTH SYS I... | 1 | 1 | 0.01% | 0.01% | 0.02% | Q3 2013 | Q4 2015 | 4 |
DVA | DAVITA HEALTHCARE PART... | 3 | 1 | 0.00% | 0.01% | 0.02% | Q3 2013 | Q4 2016 | 4 |
OCR | OMNICARE INC | 4 | 4 | 0.00% | 0.01% | 0.02% | Q2 2013 | Q1 2014 | 4 |
DRAD | DIGIRAD CORP | 4 | 4 | 0.01% | 0.01% | 0.01% | Q4 2015 | Q3 2016 | 4 |
MYGN | MYRIAD GENETICS INC | 4 | 4 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q1 2016 | 4 |
GKOS | GLAUKOS CORP | 3 | 1 | 0.00% | 0.01% | 0.02% | Q2 2016 | Q4 2018 | 4 |
PHVS | PHARVARIS NV | 4 | 4 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q4 2021 | 4 |
CASI | CASI PHARMACEUTICALS INC | 4 | 4 | 0.01% | 0.01% | 0.01% | Q4 2017 | Q3 2018 | 4 |
NSPH | NANOSPHERE INC | 4 | 4 | 0.00% | 0.00% | 0.01% | Q2 2015 | Q1 2016 | 4 |
SEVION THERAPEUTICS INC | 4 | 4 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q1 2017 | 4 | |
CBMXW | COMBIMATRIX CORPORATION | 4 | 4 | 0.00% | 0.00% | 0.00% | Q2 2013 | Q1 2014 | 4 |
TNGNQ | TENGION INC | 4 | 4 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q1 2017 | 4 |
NPCUF | ALLON THERAPEUTICS SH... | 4 | 4 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q1 2017 | 4 |
TRAVERE THERAPEUTICS INC | 3 | 3 | 1.33% | 8.37% | 14.28% | Q1 2022 | Q3 2022 | 3 | |
AGN | ALLERGAN PLC | 2 | 1 | 1.08% | 2.69% | 3.64% | Q2 2015 | Q1 2016 | 3 |
NBIX | NEUROCRINE BIOSCIENCES... | 2 | 1 | 0.27% | 1.46% | 3.00% | Q3 2013 | Q4 2014 | 3 |
BLCM | BELLICUM PHARMACEUTICA... | 2 | 1 | 0.06% | 1.32% | 2.02% | Q4 2014 | Q1 2017 | 3 |
VRTX | VERTEX PHARMACEUTICALS... | 2 | 1 | 0.28% | 1.17% | 2.23% | Q1 2014 | Q4 2014 | 3 |
AGN | ALLERGAN INC | 3 | 3 | 0.83% | 1.09% | 1.47% | Q2 2014 | Q4 2014 | 3 |
ARWR | ARROWHEAD RESH CORP | 3 | 3 | 0.55% | 1.04% | 1.98% | Q1 2014 | Q3 2014 | 3 |
NVAX | NOVAVAX INC | 3 | 3 | 0.47% | 0.95% | 1.25% | Q2 2020 | Q4 2020 | 3 |
RLMD | RELMADA THERAPEUTICS INC | 3 | 3 | 0.07% | 0.90% | 2.56% | Q1 2022 | Q3 2022 | 3 |
SNTS | SANTARUS INC | 3 | 3 | 0.17% | 0.83% | 1.33% | Q2 2013 | Q4 2013 | 3 |
ORCHESTRA BIOMED HLDGS... | 3 | 3 | 0.42% | 0.81% | 1.32% | Q1 2023 | Q3 2023 | 3 | |
BAXTER INTL INC | 3 | 3 | 0.16% | 0.77% | 1.37% | Q3 2015 | Q1 2016 | 3 | |
BEAM | BEAM THERAPEUTICS INC | 3 | 3 | 0.48% | 0.69% | 0.90% | Q1 2021 | Q3 2021 | 3 |
BELLICUM PHARMACEUTICA... | 3 | 3 | 0.60% | 0.65% | 0.71% | Q2 2015 | Q4 2015 | 3 | |
TFX | TELEFLEX INC | 3 | 3 | 0.29% | 0.61% | 1.04% | Q3 2017 | Q1 2018 | 3 |
TRVN | TREVENA INC | 3 | 3 | 0.43% | 0.53% | 0.64% | Q1 2014 | Q3 2014 | 3 |
MIRM | MIRUM PHARMACEUTICALS INC | 3 | 3 | 0.43% | 0.53% | 0.71% | Q1 2023 | Q3 2023 | 3 |
VIR | VIR BIOTECHNOLOGY INC | 2 | 1 | 0.01% | 0.50% | 1.39% | Q2 2020 | Q2 2023 | 3 |
CMPS | COMPASS PATHWAYS PLC | 3 | 3 | 0.37% | 0.48% | 0.54% | Q3 2020 | Q1 2021 | 3 |
ADMS | ADAMAS PHARMACEUTICALS... | 3 | 3 | 0.23% | 0.46% | 0.73% | Q1 2018 | Q3 2018 | 3 |
JAZZ | JAZZ PHARMACEUTICALS ... | 3 | 3 | 0.25% | 0.44% | 0.67% | Q4 2016 | Q2 2017 | 3 |
AMGN | AMGEN SHARES | 1 | 1 | 0.19% | 0.44% | 0.84% | Q3 2013 | Q4 2017 | 3 |
CYTEK BIOSCIENCES INC | 3 | 3 | 0.35% | 0.42% | 0.55% | Q3 2022 | Q1 2023 | 3 | |
VNDA | VANDA PHARMACEUTICALS INC | 2 | 1 | 0.07% | 0.41% | 0.72% | Q3 2013 | Q1 2015 | 3 |
SAGE | SAGE THERAPEUTICS INC ... | 3 | 3 | 0.01% | 0.41% | 1.10% | Q1 2017 | Q3 2017 | 3 |
ACOR | ACORDA THERAPEUTICS INC | 1 | 1 | 0.03% | 0.40% | 0.96% | Q4 2016 | Q2 2019 | 3 |
PCRX | PACIRA PHARMACEUTICALS... | 1 | 1 | 0.00% | 0.36% | 1.08% | Q3 2013 | Q2 2015 | 3 |
BMEA | BIOMEA FUSION INC | 3 | 3 | 0.30% | 0.36% | 0.46% | Q1 2023 | Q3 2023 | 3 |
TCMD | TACTILE SYS TECHNOLOGY... | 3 | 3 | 0.31% | 0.36% | 0.44% | Q1 2023 | Q3 2023 | 3 |
ITCI | INTRA-CELLULAR THERAPI... | 1 | 1 | 0.04% | 0.35% | 0.56% | Q3 2017 | Q2 2023 | 3 |
AMGEN INC | 3 | 3 | 0.01% | 0.34% | 0.60% | Q3 2015 | Q1 2016 | 3 | |
TXG | 10X GENOMICS INC | 3 | 3 | 0.30% | 0.33% | 0.36% | Q3 2019 | Q1 2020 | 3 |
BCAB | BIOATLA INC | 3 | 3 | 0.20% | 0.31% | 0.38% | Q2 2021 | Q4 2021 | 3 |
LUNG | PULMONX CORP | 2 | 1 | 0.27% | 0.31% | 0.38% | Q4 2020 | Q1 2022 | 3 |
TTPH | TETRAPHASE PHARMACEUTI... | 3 | 3 | 0.28% | 0.30% | 0.33% | Q4 2014 | Q2 2015 | 3 |
LRMR | LARIMAR THERAPEUTICS INC | 3 | 3 | 0.27% | 0.30% | 0.33% | Q3 2022 | Q1 2023 | 3 |
PEN | PENUMBRA INC | 1 | 1 | 0.08% | 0.29% | 0.64% | Q4 2018 | Q4 2022 | 3 |
EW | EDWARDS LIFESCIENCES CORP | 1 | 1 | 0.02% | 0.28% | 0.79% | Q3 2015 | Q3 2022 | 3 |
URGN | UROGEN PHARMA LTD | 3 | 3 | 0.24% | 0.27% | 0.32% | Q2 2017 | Q4 2017 | 3 |
CUE HEALTH INC | 3 | 3 | 0.20% | 0.27% | 0.33% | Q3 2021 | Q1 2022 | 3 | |
VSTM | VERASTEM INC | 3 | 3 | 0.25% | 0.27% | 0.30% | Q3 2013 | Q1 2014 | 3 |
PTI | PROTEOSTASIS THERAPEUT... | 3 | 3 | 0.21% | 0.26% | 0.35% | Q1 2016 | Q3 2016 | 3 |
PBYI | PUMA BIOTECHNOLOGY INC | 2 | 1 | 0.00% | 0.25% | 0.70% | Q2 2015 | Q1 2018 | 3 |
GMED | GLOBUS MED INC | 1 | 1 | 0.08% | 0.24% | 0.48% | Q1 2014 | Q4 2017 | 3 |
RGEN | REPLIGEN INC | 1 | 1 | 0.13% | 0.22% | 0.34% | Q3 2017 | Q2 2021 | 3 |
VKTX | VIKING THERAPEUTICS INC | 2 | 1 | 0.03% | 0.22% | 0.43% | Q3 2018 | Q2 2023 | 3 |
FLXN | FLEXION THERAPEUTICS INC | 3 | 3 | 0.19% | 0.22% | 0.26% | Q4 2017 | Q2 2018 | 3 |
HCAQ | HEALTHCOR CATALIO ACQU... | 3 | 3 | 0.19% | 0.20% | 0.22% | Q1 2021 | Q3 2021 | 3 |
VTAE | VITAE PHARMACEUTICALS INC | 3 | 3 | 0.13% | 0.19% | 0.27% | Q2 2015 | Q4 2015 | 3 |
OXFD | OXFORD IMMUNOTEC GLOBA... | 3 | 3 | 0.04% | 0.19% | 0.30% | Q2 2017 | Q4 2017 | 3 |
ZYNE | ZYNERBA PHARMACEUTICAL... | 2 | 1 | 0.02% | 0.18% | 0.51% | Q2 2017 | Q4 2019 | 3 |
SNN | SMITH & NEPHEW PLC | 3 | 3 | 0.12% | 0.18% | 0.21% | Q2 2014 | Q4 2014 | 3 |
IMMUNEERING CORP | 3 | 3 | 0.09% | 0.17% | 0.26% | Q3 2021 | Q1 2022 | 3 | |
AMRS | AMYRIS INC | 3 | 3 | 0.10% | 0.15% | 0.22% | Q2 2020 | Q4 2020 | 3 |
CERN | CERNER CORP | 3 | 3 | 0.12% | 0.15% | 0.18% | Q3 2019 | Q1 2020 | 3 |
XFOR | X4 PHARMACEUTICALS INC | 3 | 3 | 0.12% | 0.15% | 0.20% | Q1 2023 | Q3 2023 | 3 |
IMMU | IMMUNOMEDICS INC | 2 | 1 | 0.06% | 0.14% | 0.20% | Q1 2015 | Q2 2020 | 3 |
HOLX | HOLOGIC INC | 2 | 1 | 0.04% | 0.14% | 0.21% | Q1 2016 | Q3 2020 | 3 |
NLTX | NEOLEUKIN THERAPEUTICS... | 3 | 3 | 0.12% | 0.14% | 0.14% | Q4 2019 | Q2 2020 | 3 |
BOTA | BIOTA PHARMACEUTIALS ... | 3 | 3 | 0.07% | 0.13% | 0.27% | Q1 2014 | Q3 2014 | 3 |
INNL | INNOCOLL HOLDINGS PLC | 3 | 3 | 0.00% | 0.13% | 0.21% | Q2 2016 | Q4 2016 | 3 |
VVUS | VIVUS INC | 3 | 3 | 0.06% | 0.13% | 0.22% | Q3 2013 | Q1 2014 | 3 |
LGVWU | LONGVIEW ACQUISITION CORP | 3 | 3 | 0.10% | 0.13% | 0.16% | Q2 2020 | Q4 2020 | 3 |
OCRX | OCERA THERAPEUTICS SH... | 3 | 3 | 0.09% | 0.12% | 0.16% | Q1 2017 | Q3 2017 | 3 |
SWAV | SHOCKWAVE MED INC | 2 | 1 | 0.03% | 0.12% | 0.20% | Q1 2019 | Q4 2019 | 3 |
INTEC PHARMA LTD JERUS... | 3 | 3 | 0.07% | 0.11% | 0.16% | Q3 2015 | Q1 2016 | 3 | |
APVO | APTEVO THERAPEUTICS S... | 3 | 3 | 0.00% | 0.11% | 0.17% | Q3 2016 | Q1 2017 | 3 |
SIGHT SCIENCES INC | 3 | 3 | 0.09% | 0.11% | 0.13% | Q3 2021 | Q1 2022 | 3 | |
RARX | RA PHARMACEUTICALS SH... | 2 | 1 | 0.01% | 0.10% | 0.18% | Q4 2016 | Q3 2019 | 3 |
NVTRQ | NUVECTRA CORP | 3 | 3 | 0.08% | 0.10% | 0.14% | Q1 2018 | Q3 2018 | 3 |
TBIO | TRANSGENOMIC INC | 3 | 3 | 0.07% | 0.09% | 0.12% | Q2 2013 | Q4 2013 | 3 |
NKTR | NEKTAR THERAPEUTICS | 2 | 1 | 0.01% | 0.09% | 0.25% | Q2 2015 | Q2 2018 | 3 |
FIAT CHRYSLER AUTOMOBI... | 3 | 3 | 0.02% | 0.09% | 0.23% | Q1 2019 | Q3 2019 | 3 | |
ABT | ABBOTT LABORATORIES S... | 3 | 3 | 0.00% | 0.09% | 0.14% | Q3 2016 | Q1 2017 | 3 |
DNAY | CODEX DNA INC | 3 | 3 | 0.07% | 0.09% | 0.12% | Q2 2021 | Q4 2021 | 3 |
QTRX | QUANTERIX CORP | 2 | 1 | 0.04% | 0.08% | 0.12% | Q4 2017 | Q2 2023 | 3 |
MDCO | MEDICINES CO | 2 | 1 | 0.02% | 0.08% | 0.21% | Q4 2015 | Q3 2019 | 3 |
BCLI | BRAINSTORM CELL THERAP... | 1 | 1 | 0.06% | 0.08% | 0.10% | Q4 2015 | Q1 2017 | 3 |
DA32 LIFE SCNCE TEC AC... | 3 | 3 | 0.07% | 0.08% | 0.10% | Q3 2021 | Q1 2022 | 3 | |
KPTI | KARYOPHARM THERAPEUTIC... | 2 | 1 | 0.01% | 0.08% | 0.21% | Q2 2014 | Q4 2019 | 3 |
LSACU | LIFESCI ACQUISITION CORP | 3 | 3 | 0.05% | 0.06% | 0.08% | Q1 2020 | Q3 2020 | 3 |
CHFWU | CONSONANCE HFW ACQUISI... | 3 | 3 | 0.06% | 0.06% | 0.07% | Q4 2020 | Q2 2021 | 3 |
RAPID MICRO BIOSYSTEMS... | 3 | 3 | 0.03% | 0.06% | 0.09% | Q3 2021 | Q1 2022 | 3 | |
SBBP | STRONGBRIDGE BIOPHARMA... | 3 | 3 | 0.04% | 0.06% | 0.07% | Q4 2017 | Q2 2018 | 3 |
CLDX | CELLDEX THERAPEUTICS ... | 1 | 1 | 0.00% | 0.06% | 0.15% | Q4 2014 | Q1 2017 | 3 |
DCPH | DECIPHERA PHARMACEUTIC... | 2 | 1 | 0.02% | 0.06% | 0.08% | Q3 2017 | Q4 2019 | 3 |
NSPH | NANOSPHERE INC | 2 | 1 | 0.02% | 0.05% | 0.08% | Q3 2013 | Q4 2014 | 3 |
BNR | BURNING ROCK BIOTECH LTD | 3 | 3 | 0.04% | 0.05% | 0.07% | Q2 2020 | Q4 2020 | 3 |
VICL | VICAL INC | 3 | 3 | 0.03% | 0.05% | 0.07% | Q4 2017 | Q2 2018 | 3 |
DFHTU | DEERFIELD HEALTHCARE T... | 3 | 3 | 0.05% | 0.05% | 0.05% | Q3 2020 | Q1 2021 | 3 |
OSUR | ORASURE TECHNOLOGIES ... | 3 | 3 | 0.04% | 0.04% | 0.05% | Q1 2017 | Q3 2017 | 3 |
SGTX | SIGILON THERAPEUTICS INC | 3 | 3 | 0.02% | 0.04% | 0.06% | Q4 2020 | Q2 2021 | 3 |
VWR | VWR CORP | 3 | 3 | 0.03% | 0.04% | 0.04% | Q1 2016 | Q3 2016 | 3 |
PZRXQ | PHASERX INC | 3 | 3 | 0.02% | 0.04% | 0.06% | Q2 2016 | Q4 2016 | 3 |
HSKA | HESKA SHARES | 3 | 3 | 0.02% | 0.03% | 0.04% | Q1 2017 | Q3 2017 | 3 |
PRAH | PRA HEALTH SCIENCES S... | 1 | 1 | 0.02% | 0.03% | 0.04% | Q1 2016 | Q3 2017 | 3 |
AVGR | AVINGER INC | 2 | 1 | 0.00% | 0.03% | 0.10% | Q1 2015 | Q4 2016 | 3 |
ALMOST FAMILY INC | 3 | 3 | 0.01% | 0.03% | 0.04% | Q4 2015 | Q2 2016 | 3 | |
LH | LABORATORY CORPORATION... | 2 | 1 | 0.02% | 0.03% | 0.04% | Q1 2015 | Q3 2016 | 3 |
ABC | AMERISOURCEBERGEN CORP | 2 | 1 | 0.02% | 0.03% | 0.04% | Q4 2015 | Q3 2016 | 3 |
XNPT | XENOPORT INC | 3 | 3 | 0.02% | 0.03% | 0.04% | Q3 2013 | Q1 2014 | 3 |
APHB | AMPLIPHI BIOSCIENCES CORP | 3 | 3 | 0.02% | 0.02% | 0.03% | Q3 2015 | Q1 2016 | 3 |
ACHAOGEN INC | 3 | 3 | 0.02% | 0.02% | 0.03% | Q2 2015 | Q4 2015 | 3 | |
TRHC | TABULA RASA HEALTHCARE... | 3 | 3 | 0.02% | 0.02% | 0.03% | Q1 2018 | Q3 2018 | 3 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 2 | 1 | 0.01% | 0.02% | 0.04% | Q1 2018 | Q4 2018 | 3 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 0.00% | 0.02% | 0.03% | Q2 2016 | Q2 2020 | 3 |
DHR | DANAHER SHARES | 2 | 1 | 0.00% | 0.02% | 0.05% | Q2 2015 | Q1 2017 | 3 |
NTLA | INTELLIA THERAPEUTICS INC | 3 | 3 | 0.01% | 0.02% | 0.02% | Q2 2016 | Q4 2016 | 3 |
MDSO | MEDIDATA SOLUTIONS INC | 2 | 1 | 0.01% | 0.02% | 0.03% | Q4 2013 | Q3 2016 | 3 |
GTHX | G1 THERAPEUTICS INC | 2 | 1 | 0.01% | 0.02% | 0.02% | Q2 2018 | Q3 2019 | 3 |
PDLI | PDL BIOPHARMA INC | 3 | 3 | 0.01% | 0.01% | 0.02% | Q2 2014 | Q4 2014 | 3 |
KRTX | KARUNA THERAPEUTICS INC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q4 2019 | Q2 2020 | 3 |
IPXL | IMPAX LABORATORIES INC | 2 | 1 | 0.00% | 0.01% | 0.02% | Q4 2013 | Q4 2016 | 3 |
KRMD | REPRO MED SYS INC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q4 2019 | Q2 2020 | 3 |
ROCKLEY PHOTONICS HOLD... | 3 | 3 | 0.01% | 0.01% | 0.02% | Q3 2021 | Q1 2022 | 3 | |
TGTX | TG THERAPEUTICS INC | 2 | 1 | 0.01% | 0.01% | 0.01% | Q2 2018 | Q3 2020 | 3 |
HNGR | HANGER INC | 2 | 1 | 0.00% | 0.01% | 0.01% | Q2 2013 | Q3 2016 | 3 |
SOMALOGIC INC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q1 2022 | 3 | |
MD | MEDNAX INC | 2 | 1 | 0.00% | 0.00% | 0.01% | Q2 2013 | Q3 2016 | 3 |
ICEL | CELLULAR DYNAMICS INTL... | 3 | 3 | 0.00% | 0.00% | 0.00% | Q3 2014 | Q1 2015 | 3 |
CYTOKINETICS INC | 2 | 2 | 3.19% | 3.52% | 3.86% | Q2 2020 | Q3 2020 | 2 | |
GWPH | GW PHARMACEUTICALS -ADR | 2 | 2 | 2.06% | 2.12% | 2.19% | Q3 2015 | Q4 2015 | 2 |
ALXN | ALEXION PHARMACEUTICAL... | 2 | 2 | 1.51% | 2.12% | 2.73% | Q1 2018 | Q2 2018 | 2 |
SOLENO THERAPEUTICS INC | 2 | 2 | 0.27% | 1.65% | 3.03% | Q2 2023 | Q3 2023 | 2 | |
CLCD | COLUCID PHARMACEUTICAL... | 2 | 2 | 1.36% | 1.51% | 1.66% | Q3 2016 | Q4 2016 | 2 |
CPXX | CELATOR PHARMACEUTICAL... | 2 | 2 | 1.06% | 1.41% | 1.75% | Q1 2016 | Q2 2016 | 2 |
SNTA | SYNTA PHARMACEUTICALS ... | 2 | 2 | 1.24% | 1.30% | 1.36% | Q2 2013 | Q3 2013 | 2 |
IWM | ISHARES RUSSELL 2000 | 1 | 1 | 0.85% | 1.30% | 1.74% | Q3 2013 | Q3 2015 | 2 |
MNKD | MANNKIND CORP | 2 | 2 | 0.14% | 1.26% | 2.38% | Q3 2013 | Q4 2013 | 2 |
SGEN | SEAGEN INC | 2 | 2 | 1.24% | 1.25% | 1.26% | Q2 2022 | Q3 2022 | 2 |
DISC MEDICINE INC | 2 | 2 | 0.96% | 1.18% | 1.40% | Q2 2023 | Q3 2023 | 2 | |
GILD | GILEAD SCIENCES INC | 2 | 2 | 0.78% | 1.10% | 1.41% | Q2 2015 | Q3 2015 | 2 |
CTIC | CELL THERAPEUTICS INC | 2 | 2 | 0.86% | 0.90% | 0.93% | Q3 2013 | Q4 2013 | 2 |
ZSPH | ZS PHARMA INC | 2 | 2 | 0.61% | 0.88% | 1.14% | Q1 2015 | Q2 2015 | 2 |
P103PS | NPS PHARMACEUTICALS INC | 2 | 2 | 0.80% | 0.83% | 0.86% | Q2 2013 | Q3 2013 | 2 |
STJ | ST JUDE MED INC | 1 | 1 | 0.26% | 0.76% | 1.26% | Q3 2015 | Q2 2016 | 2 |
ALDER BIOPHARMACEUTICA... | 2 | 2 | 0.69% | 0.75% | 0.81% | Q1 2016 | Q2 2016 | 2 | |
BDTX | BLACK DIAMOND THERAPEU... | 2 | 2 | 0.71% | 0.72% | 0.72% | Q1 2020 | Q2 2020 | 2 |
EXAS | EXACT SCIENCES CORP P... | 1 | 1 | 0.05% | 0.69% | 1.34% | Q1 2014 | Q4 2016 | 2 |
ZFGN | ZAFGEN INC | 2 | 2 | 0.58% | 0.65% | 0.72% | Q3 2014 | Q4 2014 | 2 |
ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.02% | 0.56% | 1.11% | Q3 2013 | Q2 2014 | 2 |
SSO | PROSHARES ULTRA S & P500 | 2 | 2 | 0.19% | 0.54% | 0.89% | Q2 2015 | Q3 2015 | 2 |
HTWR | HEARTWARE INTL INC | 2 | 2 | 0.03% | 0.49% | 0.96% | Q3 2013 | Q4 2013 | 2 |
ATHN | ATHENAHEALTH SHARES | 1 | 1 | 0.33% | 0.48% | 0.63% | Q3 2017 | Q2 2018 | 2 |
VYNE | VYNE THERAPEUTICS INC | 2 | 2 | 0.39% | 0.47% | 0.55% | Q3 2020 | Q4 2020 | 2 |
SUPERNUS PHARMACEUTICA... | 2 | 2 | 0.42% | 0.47% | 0.52% | Q1 2015 | Q2 2015 | 2 | |
CMTA | CLEMENTIA PHARMACEUTIC... | 1 | 1 | 0.24% | 0.46% | 0.67% | Q3 2017 | Q4 2018 | 2 |
BAXTER INTERNATIONAL INC | 2 | 2 | 0.28% | 0.46% | 0.63% | Q4 2015 | Q1 2016 | 2 | |
BIOHAVEN LTD | 2 | 2 | 0.22% | 0.44% | 0.65% | Q2 2023 | Q3 2023 | 2 | |
CVS | CVS CAREMARK CORPORATION | 2 | 2 | 0.01% | 0.39% | 0.77% | Q3 2013 | Q4 2013 | 2 |
ABLX | ABLYNX NV | 2 | 2 | 0.21% | 0.39% | 0.56% | Q4 2017 | Q1 2018 | 2 |
BHC | BAUSCH HEALTH COS INC | 2 | 2 | 0.35% | 0.38% | 0.42% | Q1 2019 | Q2 2019 | 2 |
RCUS | ARCUS BIOSCIENCES INC | 1 | 1 | 0.26% | 0.38% | 0.51% | Q1 2022 | Q3 2022 | 2 |
PCYC | PHARMACYCLICS INC | 1 | 1 | 0.24% | 0.37% | 0.50% | Q3 2014 | Q1 2015 | 2 |
ASTX | ASTEX PHARMACEUTICALS INC | 2 | 2 | 0.03% | 0.36% | 0.68% | Q2 2013 | Q3 2013 | 2 |
PTBI | PLASMATECH BIOPHARMACE... | 2 | 2 | 0.30% | 0.34% | 0.37% | Q4 2014 | Q1 2015 | 2 |
TERN | TERNS PHARMACEUTICALS INC | 1 | 1 | 0.18% | 0.33% | 0.47% | Q1 2023 | Q3 2023 | 2 |
TSRO | TESARO INC | 1 | 1 | 0.29% | 0.30% | 0.30% | Q2 2014 | Q2 2016 | 2 |
CASC | CASCADIAN THERAPEUTICS... | 2 | 2 | 0.22% | 0.29% | 0.36% | Q2 2016 | Q3 2016 | 2 |
KERX | KERYX BIOPHARMACEUTICALS | 2 | 2 | 0.24% | 0.27% | 0.30% | Q3 2014 | Q4 2014 | 2 |
PPHMP | PEREGRINE PHARMACEUTIC... | 2 | 2 | 0.25% | 0.26% | 0.28% | Q4 2016 | Q1 2017 | 2 |
RLYP | RELYPSA INC | 1 | 1 | 0.13% | 0.25% | 0.37% | Q3 2015 | Q2 2016 | 2 |
RDUS | RADIUS HEALTH INC REGI... | 2 | 2 | 0.03% | 0.24% | 0.46% | Q1 2017 | Q2 2017 | 2 |
CYAD | CELYAD SA | 2 | 2 | 0.24% | 0.24% | 0.25% | Q2 2015 | Q3 2015 | 2 |
LIVN | LIVANOVA PLC | 1 | 1 | 0.11% | 0.24% | 0.37% | Q3 2018 | Q1 2019 | 2 |
RPTP | RAPTOR PHARMACEUTICAL ... | 2 | 2 | 0.22% | 0.24% | 0.25% | Q1 2015 | Q2 2015 | 2 |
ECYT | ENDOCYTE INC | 2 | 2 | 0.21% | 0.23% | 0.26% | Q3 2013 | Q4 2013 | 2 |
EOLS | EVOLUS INC | 1 | 1 | 0.01% | 0.23% | 0.45% | Q1 2019 | Q3 2023 | 2 |
AXGT | AXOVANT SCIENCES LTD R... | 2 | 2 | 0.08% | 0.22% | 0.35% | Q1 2017 | Q2 2017 | 2 |
IRWD | IRONWOOD PHARMACEUTICA... | 2 | 2 | 0.07% | 0.22% | 0.36% | Q2 2015 | Q3 2015 | 2 |
NBS | NEOSTEM INC | 2 | 2 | 0.19% | 0.21% | 0.23% | Q3 2013 | Q4 2013 | 2 |
CMIIU | CM LIFE SCIENCES II INC | 2 | 2 | 0.20% | 0.21% | 0.22% | Q1 2021 | Q2 2021 | 2 |
IDIX | IDENIX PHARMACEUTICALS... | 2 | 2 | 0.19% | 0.20% | 0.22% | Q4 2013 | Q1 2014 | 2 |
VTL | VITAL THERAPIES INC | 1 | 1 | 0.01% | 0.20% | 0.38% | Q2 2015 | Q1 2018 | 2 |
IMVTU | IMMUNOVANT INC | 2 | 2 | 0.19% | 0.20% | 0.20% | Q4 2019 | Q1 2020 | 2 |
ARVN | ARVINAS INC | 1 | 1 | 0.06% | 0.19% | 0.33% | Q3 2018 | Q4 2019 | 2 |
LANDOS BIOPHARMA INC | 2 | 2 | 0.18% | 0.19% | 0.19% | Q2 2023 | Q3 2023 | 2 | |
CMLTU | CM LIFE SCIENCES III INC | 2 | 2 | 0.18% | 0.18% | 0.19% | Q2 2021 | Q3 2021 | 2 |
GNCA | GENOCEA BIOSCIENCES INC | 2 | 2 | 0.01% | 0.18% | 0.35% | Q1 2016 | Q2 2016 | 2 |
PPH | VANECK VECTORS ETF TR | 2 | 2 | 0.14% | 0.16% | 0.18% | Q3 2020 | Q4 2020 | 2 |
ASPX | AUSPEX PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.16% | 0.28% | Q3 2014 | Q1 2015 | 2 |
XERS | XERIS PHARMACEUTICALS INC | 2 | 2 | 0.09% | 0.16% | 0.22% | Q2 2018 | Q3 2018 | 2 |
KYMR | KYMERA THERAPEUTICS INC | 2 | 2 | 0.15% | 0.15% | 0.15% | Q3 2021 | Q4 2021 | 2 |
ZLAB | ZAI LAB LTD | 2 | 2 | 0.12% | 0.15% | 0.18% | Q3 2017 | Q4 2017 | 2 |
NLNK | NEWLINK GENETICS CORP | 2 | 2 | 0.12% | 0.15% | 0.18% | Q3 2017 | Q4 2017 | 2 |
EXEL | EXELIXIS INC | 2 | 2 | 0.13% | 0.14% | 0.15% | Q1 2014 | Q2 2014 | 2 |
CATABASIS PHARMACEUTIC... | 2 | 2 | 0.07% | 0.14% | 0.21% | Q1 2021 | Q2 2021 | 2 | |
NLNK | NEWLINK GENETICS CORP | 2 | 2 | 0.13% | 0.14% | 0.15% | Q1 2014 | Q2 2014 | 2 |
ALIM | ALIMERA SCIENCES INC | 2 | 2 | 0.09% | 0.13% | 0.18% | Q4 2014 | Q1 2015 | 2 |
ICAD | ICAD INC | 2 | 2 | 0.09% | 0.13% | 0.17% | Q1 2014 | Q2 2014 | 2 |
NSTG | NANOSTRING TECHNOLOGIE... | 1 | 1 | 0.01% | 0.13% | 0.24% | Q3 2016 | Q4 2020 | 2 |
PETX | ARATANA THERAPEUTICS INC | 2 | 2 | 0.11% | 0.13% | 0.14% | Q1 2016 | Q2 2016 | 2 |
UUP | POWERSHS DB US DOLLAR ... | 2 | 2 | 0.11% | 0.12% | 0.14% | Q2 2015 | Q3 2015 | 2 |
HIIQ | HEALTH INS INNOVATIO... | 2 | 2 | 0.06% | 0.11% | 0.17% | Q3 2014 | Q4 2014 | 2 |
GWPH | GW PHARMACEUTICALS PLC | 1 | 1 | 0.08% | 0.11% | 0.14% | Q1 2016 | Q3 2017 | 2 |
JUNO | JUNO THERAPEUTICS INC | 1 | 1 | 0.00% | 0.11% | 0.22% | Q4 2014 | Q2 2016 | 2 |
TKMR | TEKMIRA PHARMACEUTICAL... | 2 | 2 | 0.09% | 0.11% | 0.12% | Q2 2013 | Q3 2013 | 2 |
MNKD | MANNKIND CORP | 2 | 2 | 0.09% | 0.11% | 0.13% | Q3 2014 | Q4 2014 | 2 |
HSACU | HEALTH SCIENCES ACQUIS... | 2 | 2 | 0.10% | 0.11% | 0.12% | Q2 2019 | Q3 2019 | 2 |
DYN | DYNE THERAPEUTICS INC | 2 | 2 | 0.09% | 0.10% | 0.12% | Q3 2020 | Q4 2020 | 2 |
STIM | NEURONETICS INC | 2 | 2 | 0.09% | 0.10% | 0.12% | Q2 2018 | Q3 2018 | 2 |
INCY | INCYTE CORP | 1 | 1 | 0.00% | 0.10% | 0.20% | Q3 2017 | Q1 2018 | 2 |
ACELYRIN INC | 2 | 2 | 0.07% | 0.09% | 0.12% | Q2 2023 | Q3 2023 | 2 | |
DERMTECH INC | 2 | 2 | 0.08% | 0.09% | 0.10% | Q1 2020 | Q2 2020 | 2 | |
LGND | LIGAND PHARMACEUTICAL... | 2 | 2 | 0.01% | 0.09% | 0.17% | Q2 2014 | Q3 2014 | 2 |
OPHT | OPHTHOTECH CORP CALL... | 2 | 2 | 0.00% | 0.09% | 0.18% | Q3 2016 | Q4 2016 | 2 |
PTBIW | PLASMATECH BIOPHARMACE... | 2 | 2 | 0.08% | 0.09% | 0.09% | Q4 2014 | Q1 2015 | 2 |
SIC | SELECT INTERIOR CONCEP... | 2 | 2 | 0.02% | 0.09% | 0.15% | Q3 2019 | Q4 2019 | 2 |
TTNP | TITAN PHARMACEUTICALS ... | 2 | 2 | 0.00% | 0.09% | 0.17% | Q4 2015 | Q1 2016 | 2 |
CASC | CASCADIAN THERAPEUTICS... | 2 | 2 | 0.00% | 0.08% | 0.17% | Q4 2016 | Q1 2017 | 2 |
VBI VACCINES INC CDA | 2 | 2 | 0.03% | 0.08% | 0.13% | Q2 2023 | Q3 2023 | 2 | |
OREX | OREXIGEN THERAPEUTICS INC | 1 | 1 | 0.02% | 0.08% | 0.14% | Q2 2014 | Q2 2015 | 2 |
ABIOMED INC | 1 | 1 | 0.04% | 0.08% | 0.11% | Q2 2015 | Q2 2016 | 2 | |
SNDX | SYNDAX PHARMACEUTICALS... | 2 | 2 | 0.07% | 0.07% | 0.08% | Q4 2020 | Q1 2021 | 2 |
VINC | VINCERX PHARMA INC | 2 | 2 | 0.07% | 0.07% | 0.07% | Q4 2020 | Q1 2021 | 2 |
LGVU | LONGVIEW ACQUISITION C... | 2 | 2 | 0.06% | 0.06% | 0.06% | Q1 2021 | Q2 2021 | 2 |
ARQT | ARCUTIS BIOTHERAPEUTIC... | 2 | 2 | 0.04% | 0.06% | 0.09% | Q2 2023 | Q3 2023 | 2 |
ADMP | ADAMIS PHARMACEUTICALS... | 1 | 1 | 0.01% | 0.06% | 0.10% | Q2 2017 | Q3 2018 | 2 |
GERN | GERON CORP | 1 | 1 | 0.02% | 0.06% | 0.10% | Q1 2018 | Q3 2018 | 2 |
IMPR | IMPRIVATA INC | 2 | 2 | 0.05% | 0.06% | 0.06% | Q1 2015 | Q2 2015 | 2 |
PNT | POINT BIOPHARMA GLOBAL... | 2 | 2 | 0.02% | 0.05% | 0.09% | Q2 2023 | Q3 2023 | 2 |
GNMX | AEVI GENOMIC MEDICINE ... | 2 | 2 | 0.00% | 0.05% | 0.11% | Q4 2016 | Q1 2017 | 2 |
THLD | THRESHOLD PHARMACEUTI... | 2 | 2 | 0.04% | 0.05% | 0.06% | Q3 2014 | Q4 2014 | 2 |
KNSA | KINIKSA PHARMACEUTICAL... | 2 | 2 | 0.04% | 0.04% | 0.05% | Q2 2018 | Q3 2018 | 2 |
XENT | INTERSECT ENT INC | 1 | 1 | 0.02% | 0.04% | 0.06% | Q2 2015 | Q1 2019 | 2 |
MTST | METASTAT SHARES | 2 | 2 | 0.04% | 0.04% | 0.04% | Q4 2016 | Q1 2017 | 2 |
BLRX | BIOLINERX LTD | 2 | 2 | 0.03% | 0.04% | 0.04% | Q1 2014 | Q2 2014 | 2 |
BGNE | BEIGENE LTD | 2 | 2 | 0.00% | 0.04% | 0.07% | Q3 2019 | Q4 2019 | 2 |
HUM | HUMANA INC CALL 210 0... | 2 | 2 | 0.03% | 0.04% | 0.04% | Q3 2016 | Q4 2016 | 2 |
ACHI | ACCRETIVE HEALTH INC | 2 | 2 | 0.02% | 0.04% | 0.05% | Q3 2016 | Q4 2016 | 2 |
IMDZ | IMMUNE DESIGN CORP | 2 | 2 | 0.03% | 0.03% | 0.04% | Q3 2016 | Q4 2016 | 2 |
QHCCQ | QUORUM HEALTH SHARES | 2 | 2 | 0.02% | 0.03% | 0.05% | Q4 2016 | Q1 2017 | 2 |
CMLF | CM LIFE SCIENCES INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2021 | Q2 2021 | 2 |
KND | KINDRED HEATHCARE INC | 2 | 2 | 0.03% | 0.03% | 0.03% | Q2 2016 | Q3 2016 | 2 |
AMEDISYS INC | 2 | 2 | 0.01% | 0.03% | 0.04% | Q4 2015 | Q1 2016 | 2 | |
ANTM | ANTHEM SHARES | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2016 | Q1 2017 | 2 |
LEAP THERAPEUTICS INC | 2 | 2 | 0.00% | 0.03% | 0.05% | Q2 2023 | Q3 2023 | 2 | |
INSYQ | INSYS THERAPEUTICS INC... | 2 | 2 | 0.03% | 0.03% | 0.03% | Q4 2013 | Q1 2014 | 2 |
NAVB | NAVIDEA BIOPHARMACEUTI... | 2 | 2 | 0.02% | 0.02% | 0.02% | Q3 2013 | Q4 2013 | 2 |
ALGN | ALIGN TECHNOLOGY INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q3 2017 | Q4 2017 | 2 |
ESRX | EXPRESS SCRIPTS HOLDING | 1 | 1 | 0.02% | 0.02% | 0.03% | Q4 2013 | Q4 2016 | 2 |
NVAX | NOVAVAX INC | 1 | 1 | 0.02% | 0.02% | 0.03% | Q2 2016 | Q4 2016 | 2 |
PTIE | PAIN THERAPEUTICS INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q4 2013 | Q1 2014 | 2 |
LVGO | LIVONGO HEALTH INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q2 2020 | Q3 2020 | 2 |
AFAM | ALMOST FAMILY INC | 1 | 1 | 0.01% | 0.02% | 0.03% | Q2 2014 | Q3 2016 | 2 |
PLXP | PLX PHARMA INC | 2 | 2 | 0.01% | 0.02% | 0.02% | Q1 2021 | Q2 2021 | 2 |
NVCR | NOVOCURE LTD | 2 | 2 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q4 2019 | 2 |
ZGNX | ZOGENIX INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2018 | Q1 2020 | 2 |
VTL | VITAL THERAPIES INC | 1 | 1 | 0.01% | 0.02% | 0.02% | Q1 2016 | Q2 2018 | 2 |
MNKKQ | MALLINCKRODT PUB LTD CO | 1 | 1 | 0.01% | 0.02% | 0.02% | Q1 2016 | Q3 2016 | 2 |
SCLN | SCICLONE PHARMACEUTIC... | 2 | 2 | 0.01% | 0.02% | 0.02% | Q3 2014 | Q4 2014 | 2 |
RDNT | RADNET INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2014 | Q1 2015 | 2 |
CEREW | CEREVEL THERAPEUTICS H... | 2 | 2 | 0.01% | 0.02% | 0.02% | Q1 2021 | Q2 2021 | 2 |
FGEN | FIBROGEN INC | 1 | 1 | 0.01% | 0.02% | 0.02% | Q3 2017 | Q1 2019 | 2 |
CNAT | CONATUS PHARMACEUTICAL... | 2 | 2 | 0.00% | 0.02% | 0.03% | Q2 2015 | Q3 2015 | 2 |
BSTC | BIOSPECIFICS TECHNOLO... | 1 | 1 | 0.01% | 0.02% | 0.02% | Q2 2014 | Q4 2014 | 2 |
BCR | BARD C R INC | 1 | 1 | 0.01% | 0.01% | 0.02% | Q2 2014 | Q4 2014 | 2 |
PMD | PSYCHEMEDICS CORP | 2 | 2 | 0.01% | 0.01% | 0.02% | Q3 2016 | Q4 2016 | 2 |
DPLO | DIPLOMAT PHARMACY INC | 1 | 1 | 0.01% | 0.01% | 0.02% | Q2 2016 | Q2 2017 | 2 |
SEM | SELECT MED HLDGS CORP | 2 | 2 | 0.01% | 0.01% | 0.02% | Q3 2014 | Q4 2014 | 2 |
JNP | JUNIPER PHARMACEUTICAL... | 2 | 2 | 0.00% | 0.01% | 0.02% | Q2 2015 | Q3 2015 | 2 |
SCPEWS | SC HEALTH CORP | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q2 2021 | 2 |
VINCW | VINCERX PHARMA INC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q4 2020 | Q1 2021 | 2 |
ENSG | ENSIGN GROUP INC | 1 | 1 | 0.01% | 0.01% | 0.02% | Q2 2014 | Q4 2015 | 2 |
IMGN | IMMUNOGEN INC | 1 | 1 | 0.01% | 0.01% | 0.02% | Q2 2016 | Q3 2017 | 2 |
AGILE THERAPEUTICS INC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q2 2022 | Q3 2022 | 2 | |
GTIV | GENTIVA HEALTH SERVI... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2014 | Q3 2014 | 2 |
ENDP | ENDO INTL PLC | 1 | 1 | 0.01% | 0.01% | 0.02% | Q1 2014 | Q4 2016 | 2 |
DVCR | DIVERSICARE HEALTHCARE... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q3 2015 | 2 |
SURG | SYNERGETICS USA INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2015 | Q2 2015 | 2 |
FONR | FONAR CORP | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2015 | Q1 2016 | 2 |
SMA | SYMMETRY MED INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2014 | Q3 2014 | 2 |
CUE | CUE BIOPHARMA INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q2 2020 | 2 |
VCNX | VACCINEX INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2018 | Q4 2018 | 2 |
CTLT | CATALENT INC | 1 | 1 | 0.00% | 0.01% | 0.02% | Q1 2015 | Q4 2016 | 2 |
IMMU | IMMUNOMEDICS INC | 2 | 2 | 0.00% | 0.01% | 0.01% | Q4 2018 | Q1 2019 | 2 |
LLY | ELI LILLY & CO CALL 9... | 2 | 2 | 0.00% | 0.01% | 0.02% | Q3 2016 | Q4 2016 | 2 |
V107SC | WELLPOINT INC | 1 | 1 | 0.00% | 0.01% | 0.01% | Q2 2013 | Q3 2014 | 2 |
HLS | HEALTHSOUTH CORP | 2 | 2 | 0.00% | 0.01% | 0.01% | Q2 2013 | Q3 2013 | 2 |
NUVA | NUVASIVE INC | 1 | 1 | 0.00% | 0.01% | 0.01% | Q3 2015 | Q3 2016 | 2 |
MINERVA SURGICAL INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q1 2022 | 2 | |
MDAS | MEDASSETS INC | 1 | 1 | 0.00% | 0.01% | 0.01% | Q2 2013 | Q2 2014 | 2 |
CYNO | CYNOSURE INC CLASS A | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2016 | Q4 2016 | 2 |
ZIOP | ZIOPHARM ONCOLOGY INC | 1 | 1 | 0.00% | 0.01% | 0.01% | Q2 2016 | Q2 2019 | 2 |
HLF | HERBALIFE LTD | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2016 | Q2 2016 | 2 |
ENDP | ENDO HEALTH SOLUTIONS INC | 1 | 1 | 0.00% | 0.01% | 0.01% | Q2 2013 | Q4 2013 | 2 |
MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2019 | Q1 2020 | 2 |
DFHT | DEERFIELD HEALTHCARE T... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2020 | Q1 2021 | 2 |
NEPTUNE WELLNESS SOLUT... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q3 2022 | 2 | |
WST | WEST PHARMACEUTICAL SE... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q1 2017 | 2 |
SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2018 | Q2 2019 | 2 |
SOLID BIOSCIENCES INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q1 2019 | 2 | |
IDRA | IDERA PHARMACEUTICALS INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q4 2015 | 2 |
TLT | ISHARES 20 PLUS YEAR T... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q1 2017 | 2 |
TORC | RESTORBIO INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2019 | Q1 2020 | 2 |
IWS | ISHARES RUSSELL MID-CA... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q1 2017 | 2 |
IVV | ISHARES CORE SandP 500... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q1 2017 | 2 |
BSX | BOSTON SCIENTIFIC SHARES | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q1 2017 | 2 |
ONXX | ONYX PHARMACEUTICALS INC | 1 | 1 | 5.72% | 5.72% | 5.72% | Q3 2013 | Q3 2013 | 1 |
IBB | ISHARES TR | 1 | 1 | 4.72% | 4.72% | 4.72% | Q2 2013 | Q2 2013 | 1 |
IBB | ISHARES | 1 | 1 | 2.50% | 2.50% | 2.50% | Q3 2013 | Q3 2013 | 1 |
MDGL | MADRIGAL PHARMACEUTICA... | 1 | 1 | 2.44% | 2.44% | 2.44% | Q4 2022 | Q4 2022 | 1 |
PTCT | PTC THERAPEUTICS INC | 1 | 1 | 2.14% | 2.14% | 2.14% | Q3 2015 | Q3 2015 | 1 |
BIIB | BIOGEN INC | 1 | 1 | 2.12% | 2.12% | 2.12% | Q1 2021 | Q1 2021 | 1 |
CRSP | CRISPR THERAPEUTICS AG | 1 | 1 | 1.64% | 1.64% | 1.64% | Q3 2020 | Q3 2020 | 1 |
SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 1.51% | 1.51% | 1.51% | Q2 2013 | Q2 2013 | 1 |
APOGEE THERAPEUTICS INC | 1 | 1 | 1.30% | 1.30% | 1.30% | Q3 2023 | Q3 2023 | 1 | |
SNY | SANOFI | 1 | 1 | 1.23% | 1.23% | 1.23% | Q1 2023 | Q1 2023 | 1 |
SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 1.06% | 1.06% | 1.06% | Q2 2013 | Q2 2013 | 1 |
LLY | LILLY ELI & CO | 1 | 1 | 1.02% | 1.02% | 1.02% | Q2 2022 | Q2 2022 | 1 |
SLXP | SALIX PHARMACEUTICALS INC | 1 | 1 | 0.99% | 0.99% | 0.99% | Q2 2013 | Q2 2013 | 1 |
ESPR | ESPERION THERAPEUTICS INC | 1 | 1 | 0.98% | 0.98% | 0.98% | Q2 2015 | Q2 2015 | 1 |
ANACOR PHARMACEUTICALS... | 1 | 1 | 0.98% | 0.98% | 0.98% | Q4 2013 | Q4 2013 | 1 | |
BDX | BECTON DICKINSON & CO | 1 | 1 | 0.93% | 0.93% | 0.93% | Q4 2014 | Q4 2014 | 1 |
TANGO THERAPEUTICS INC | 1 | 1 | 0.91% | 0.91% | 0.91% | Q3 2023 | Q3 2023 | 1 | |
ADHD | ALCOBRA LTD | 1 | 1 | 0.89% | 0.89% | 0.89% | Q3 2014 | Q3 2014 | 1 |
NVO | NOVO-NORDISK A/S-SPONS... | 1 | 1 | 0.87% | 0.87% | 0.87% | Q3 2015 | Q3 2015 | 1 |
GENTY | GENTIUM S P A | 1 | 1 | 0.82% | 0.82% | 0.82% | Q4 2013 | Q4 2013 | 1 |
MDT | MEDTRONIC INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q2 2014 | Q2 2014 | 1 |
ADHD | ALCOBRA LTD | 1 | 1 | 0.81% | 0.81% | 0.81% | Q3 2014 | Q3 2014 | 1 |
CYTOMX THERAPEUTICS, INC | 1 | 1 | 0.75% | 0.75% | 0.75% | Q3 2016 | Q3 2016 | 1 | |
OPTR | OPTIMER PHARMACEUTICAL... | 1 | 1 | 0.72% | 0.72% | 0.72% | Q2 2013 | Q2 2013 | 1 |
HEDJ | WISDOMTREE EUROPE HEDG... | 1 | 1 | 0.70% | 0.70% | 0.70% | Q2 2016 | Q2 2016 | 1 |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q1 2014 | Q1 2014 | 1 |
CLDN | CELADON GROUP INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q1 2015 | Q1 2015 | 1 |
ELN | ELAN PLC | 1 | 1 | 0.69% | 0.69% | 0.69% | Q2 2013 | Q2 2013 | 1 |
GTXI | GTX INC DEL | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2018 | Q2 2018 | 1 |
TBPH | THERAVANCE BIOPHARMA INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q1 2020 | Q1 2020 | 1 |
ISIS | ISIS PHARMACEUTICALS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q3 2013 | Q3 2013 | 1 |
AVNR | AVANIR PHARMACEUTICAL... | 1 | 1 | 0.59% | 0.59% | 0.59% | Q3 2014 | Q3 2014 | 1 |
RAYZEBIO INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2023 | Q3 2023 | 1 | |
RGDO | REGADO BIOSCIENCES INC | 1 | 1 | 0.57% | 0.57% | 0.57% | Q2 2014 | Q2 2014 | 1 |
ITCI | INTRA-CELLULAR THERAPI... | 1 | 1 | 0.57% | 0.57% | 0.57% | Q4 2019 | Q4 2019 | 1 |
DYAX | DYAX CORP | 1 | 1 | 0.52% | 0.52% | 0.52% | Q1 2015 | Q1 2015 | 1 |
HZNP | HORIZON PHARMA PLC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q1 2016 | Q1 2016 | 1 |
ENZY | ENZYMOTEC LTD | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2014 | Q1 2014 | 1 |
NVRO | NEVRO CORP | 1 | 1 | 0.49% | 0.49% | 0.49% | Q1 2016 | Q1 2016 | 1 |
ICPT | INTERCEPT INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q2 2014 | Q2 2014 | 1 |
DVAX | DYNAVAX TECHNOLOGIES C... | 1 | 1 | 0.46% | 0.46% | 0.46% | Q3 2016 | Q3 2016 | 1 |
AMRN | AMARIN CORP PLC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2013 | Q3 2013 | 1 |
RLYP | RELYPSA INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2015 | Q3 2015 | 1 |
KMDA | KAMADA LTD | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2013 | Q2 2013 | 1 |
ALDER BIOPHARMACEUTICA... | 1 | 1 | 0.43% | 0.43% | 0.43% | Q1 2016 | Q1 2016 | 1 | |
RPRX | REPROS THERAPEUTICS INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q3 2013 | Q3 2013 | 1 |
SQNM | SEQUENOM INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q2 2013 | Q2 2013 | 1 |
NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2013 | Q2 2013 | 1 |
DNLI | DENALI THERAPEUTICS INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2020 | Q1 2020 | 1 |
WAG | WALGREEN CO | 1 | 1 | 0.36% | 0.36% | 0.36% | Q2 2014 | Q2 2014 | 1 |
ITMN | INTERMUNE INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2014 | Q1 2014 | 1 |
QDEL | QUIDEL CORP | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2014 | Q4 2014 | 1 |
ASTM | AASTROM BIOSCIENCES INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q3 2014 | Q3 2014 | 1 |
DENALI THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2020 | Q2 2020 | 1 | |
AEGR | AEGERION PHARMACEUTICA... | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2014 | Q2 2014 | 1 |
RARE | ULTRAGENYX PHARMACEUTI... | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2017 | Q2 2017 | 1 |
SNSS | SUNESIS PHARMACEUTICAL... | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2014 | Q3 2014 | 1 |
SNSS | SUNESIS PHARMACEUTICAL... | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2014 | Q3 2014 | 1 |
ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2013 | Q2 2013 | 1 |
CNDO | CORONADO BIOSCIENCES INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2013 | Q3 2013 | 1 |
AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2019 | Q4 2019 | 1 |
ANIK | ANIKA THERAPEUTICS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2013 | Q3 2013 | 1 |
SDGR | SCHRODINGER INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2020 | Q1 2020 | 1 |
UMRX | UNUM THERAPEUTICS INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2020 | Q3 2020 | 1 |
TERN | TERNS PHARMACEUTICALS INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2023 | Q2 2023 | 1 |
AFFIMED THERAPEUTICS BV | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2016 | Q1 2016 | 1 | |
OMER | OMEROS CORP | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2016 | Q1 2016 | 1 |
ZGNX | ZOGENIX INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q4 2013 | Q4 2013 | 1 |
CATALYST PHARM PARTN... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2014 | Q3 2014 | 1 | |
ECYT | ENDOCYTE INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2013 | Q4 2013 | 1 |
GILD | GILEAD SCIENCES INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2013 | Q2 2013 | 1 |
AUXL | AUXILIUM PHARMACEUTIC... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q4 2013 | Q4 2013 | 1 |
VBLX | VASCULAR BIOGENICS LTD | 1 | 1 | 0.25% | 0.25% | 0.25% | Q4 2014 | Q4 2014 | 1 |
MZOR | MAZOR ROBOTICS LTD | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2013 | Q3 2013 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2016 | Q1 2016 | 1 |
CCXI | CHEMOCENTRYX INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q3 2021 | Q3 2021 | 1 |
QCOR | QUESTCOR PHARMACEUTICA... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q2 2013 | Q2 2013 | 1 |
TKMR | TEKMIRA PHARMACEUTICAL... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2014 | Q1 2014 | 1 |
BLPH | BELLEROPHON THERAPEUTI... | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2023 | Q1 2023 | 1 |
MEI PHARMA INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2019 | Q4 2019 | 1 | |
TDOC | TELADOC HEALTH INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2021 | Q2 2021 | 1 |
PTCT | PTC THERAPEUTICS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2015 | Q3 2015 | 1 |
RTRX | RETROPHIN INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2015 | Q2 2015 | 1 |
MYOV | MYOVANT SCIENCES | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2016 | Q4 2016 | 1 |
TELADOC HEALTH INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2019 | Q3 2019 | 1 | |
RGLS | REGULUS THERAPEUTICS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q1 2016 | Q1 2016 | 1 |
SCYX | SCYNEXIS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2020 | Q4 2020 | 1 |
SCPH | SCPHARMACEUTICALS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2022 | Q4 2022 | 1 |
CGEN | COMPUGEN LTD | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2014 | Q1 2014 | 1 |
NBS | NEOSTEM INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2013 | Q2 2013 | 1 |
AKRO | AKERO THERAPEUTICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2023 | Q3 2023 | 1 |
PTE | POLARITYTE INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2018 | Q3 2018 | 1 |
ADMA BIOLOGICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2016 | Q2 2016 | 1 | |
IONS | Ionis Pharmaceuticals ... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2016 | Q2 2016 | 1 |
ANTH | ANTHERA PHARMACEUTICAL... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2013 | Q2 2013 | 1 |
CVRX | CVRX INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2021 | Q2 2021 | 1 |
ABMD | ABIOMED INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2014 | Q4 2014 | 1 |
ANTHERA PHARMACEUTICA... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2014 | Q2 2014 | 1 | |
SGEN | SEATTLE GENETICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2013 | Q2 2013 | 1 |
TCDA | TRICIDA INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2022 | Q3 2022 | 1 |
CLDN | CELADON GROUP INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2015 | Q1 2015 | 1 |
PGNX | PROGENICS PHARMACEUTICALS | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2016 | Q2 2016 | 1 |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2013 | Q3 2013 | 1 |
VPHM | VIROPHARMA INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2013 | Q2 2013 | 1 |
NCNA | NUCANA PLS | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2017 | Q3 2017 | 1 |
RGLS | REGULUS THERAPEUTICS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2015 | Q2 2015 | 1 |
EQRX INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2021 | Q4 2021 | 1 | |
PFE | PFIZER | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2016 | Q4 2016 | 1 |
NVAX | NOVAVAX INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2023 | Q3 2023 | 1 |
VICL | VICAL INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2013 | Q2 2013 | 1 |
CTIC | CTI BIOPHARMA CORP | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2022 | Q3 2022 | 1 |
SSO | PROSHARES TR | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2015 | Q2 2015 | 1 |
AMRN | AMARIN CORP PLC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2013 | Q2 2013 | 1 |
MYGN | MYRIAD GENETICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2013 | Q3 2013 | 1 |
CRIS | CURIS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2020 | Q4 2020 | 1 |
DBVT | DBV TECHNOLOGIES S A | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2017 | Q3 2017 | 1 |
MRVI | MARAVAI LIFESCIENCES H... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2020 | Q4 2020 | 1 |
MDXG | MIMEDX GROUP INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2013 | Q4 2013 | 1 |
CYCC | CYCLACEL PHARMACEUTICA... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2013 | Q2 2013 | 1 |
RMTI | ROCKWELL MEDICAL INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2019 | Q2 2019 | 1 |
MRNA | MODERNA INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2020 | Q2 2020 | 1 |
BMR | BIOMED REALTY TRUST INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2013 | Q2 2013 | 1 |
RARE | ULTRAGENYX PHARMACEUTI... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2019 | Q1 2019 | 1 |
VXX | BARCLAYS BK PLC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2016 | Q1 2016 | 1 |
SHC | SOTERA HEALTH CO | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2020 | Q4 2020 | 1 |
OREXIGEN THERAPEUTICS... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2013 | Q4 2013 | 1 | |
FGEN | FIBROGEN INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2021 | Q1 2021 | 1 |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2017 | Q3 2017 | 1 |
BLI | PHENOMEX INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2023 | Q1 2023 | 1 |
ADCT | ADC THERAPEUTICS SA | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2023 | Q1 2023 | 1 |
EYPT | EYEPOINT PHARMACEUTICA... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2023 | Q3 2023 | 1 |
CARA | CARA THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2017 | Q2 2017 | 1 |
MDCO | MEDICINES CO PUT 32 0... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2016 | Q4 2016 | 1 |
AMRN | AMARIN CORP PLC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2013 | Q3 2013 | 1 |
AKYA | AKOYA BIOSCIENCES INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2021 | Q2 2021 | 1 |
VXX | BARCLAYS BANK IPATH Sa... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2016 | Q4 2016 | 1 |
ADXS | ADVAXIS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2018 | Q1 2018 | 1 |
AKCA | AKCEA THERAPEUTICS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2018 | Q1 2018 | 1 |
ACER | ACER THERAPEUTICS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2017 | Q4 2017 | 1 |
HOLX | HOLOGIC INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2013 | Q4 2013 | 1 |
AVNR | AVANIR PHARMACEUTICALS... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2013 | Q3 2013 | 1 |
LPCN | LIPOCINE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2016 | Q2 2016 | 1 |
INCY | INCYTE CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2018 | Q1 2018 | 1 |
CHAMPIONS ONCOLOGY INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2018 | Q2 2018 | 1 | |
LPCN | LIPOCINE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2016 | Q2 2016 | 1 |
LPDX | LIPOSCIENCE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2013 | Q2 2013 | 1 |
XENON PHARMACEUTICALS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2017 | Q3 2017 | 1 | |
AKRXQ | AKORN SHARES | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2017 | Q1 2017 | 1 |
ETNB | 89BIO INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2023 | Q3 2023 | 1 |
CORV | CORREVIO PHARMA CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2019 | Q3 2019 | 1 |
SIEN | SIENTRA INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2014 | Q4 2014 | 1 |
LXRX | Lexicon Pharmaceutical... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2016 | Q2 2016 | 1 |
XNCR | XENCOR INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2015 | Q3 2015 | 1 |
NCT | NEWCASTLE INVT CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2013 | Q4 2013 | 1 |
ACRS | ACLARIS THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2023 | Q3 2023 | 1 |
MASS | 908 DEVICES INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2020 | Q4 2020 | 1 |
AVXL | ANAVEX LIFE SCIENCES CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2020 | Q4 2020 | 1 |
TBT | PROSHARES TR | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2015 | Q3 2015 | 1 |
VICL | VICAL INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2013 | Q3 2013 | 1 |
TLIS | TALIS BIOMEDICAL CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
CBIO | CATALYST BIOSCIENCES ... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2018 | Q1 2018 | 1 |
ATHN | ATHENAHEALTH INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2013 | Q4 2013 | 1 |
CCRN | CROSS COUNTRY HEALTHCARE | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2016 | Q4 2016 | 1 |
SGEN | SEATTLE GENETICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2019 | Q3 2019 | 1 |
QTNTW | QUOTIENT LTD | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2015 | Q3 2015 | 1 |
HWAY | HEALTHWAYS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2016 | Q3 2016 | 1 |
AMN HEALTHCARE SERVICE... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2016 | Q2 2016 | 1 | |
IMAGO BIOSCIENCES INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2021 | Q3 2021 | 1 | |
AVDR | AVEDRO INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2019 | Q1 2019 | 1 |
AEGLEA BIOTHERAPEUTICS... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2023 | Q3 2023 | 1 | |
T107PS | WRIGHT MED GROUP INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2014 | Q1 2014 | 1 |
MASI | MASIMO SHARES | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2017 | Q1 2017 | 1 |
A | AGILENT TECHNOLOGIES INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2016 | Q3 2016 | 1 |
HMSY | HMS HOLDINGS SHARES | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2017 | Q1 2017 | 1 |
MDRX | ALLSCRIPTS HEALTHCARE ... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2017 | Q1 2017 | 1 |
CNMD | CONMED CORP | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2015 | Q2 2015 | 1 |
ATHENEX INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2023 | Q1 2023 | 1 | |
DCPH | DECIPHERA PHARMACEUTIC... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 |
QSII | QUALITY SYSTEMS SHARES | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2017 | Q1 2017 | 1 |
SPY | SPDR S&P 500 ETF TR | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2016 | Q1 2016 | 1 |
HPTX | HYPERION THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 |
MYGN | MYRIAD GENETICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2013 | Q4 2013 | 1 |
GALE | GALENA BIOPHARMA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 |
TRNX | TORNIER N V | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2013 | Q4 2013 | 1 |
SKH | SKILLED HEALTHCARE G... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 |
IRIX | IRIDEX | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2016 | Q4 2016 | 1 |
ATRA | ATARA BIOTHERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2017 | Q3 2017 | 1 |
VCYT | VERACYTE INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2019 | Q1 2019 | 1 |
CYBX | CYBERONICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 |
VRX | VALEANT PHARMACEUTICAL... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2017 | Q4 2017 | 1 |
PTX | PERNIX THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2014 | Q3 2014 | 1 |
EARS | AURIS MEDICAL HOLDING ... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2017 | Q1 2017 | 1 |
RIGL | RIGEL PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2014 | Q1 2014 | 1 |
PRTK | PARATEK PHARMACEUTICAL... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2017 | Q3 2017 | 1 |
INOV | INOVALON HLDGS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2017 | Q3 2017 | 1 |
VRNA | VERONA PHARMA PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 |
MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 |
SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2017 | Q4 2017 | 1 |
BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q3 2019 | 1 |
PRXL | PAREXEL INTL CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 |
CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2019 | Q1 2019 | 1 |
CIVI | CIVITAS SOLUTIONS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 |
CSLT | CASTLIGHT HEALTH INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2014 | Q1 2014 | 1 |
ADDUS HOMECARE CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2015 | Q3 2015 | 1 | |
USPH | U S PHYSICAL THERAP... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 |
ASTRAZENECA PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2013 | Q4 2013 | 1 | |
ANALOGIC CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2013 | Q4 2013 | 1 | |
FURX | FURIEX PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2013 | Q3 2013 | 1 |
LOXO | LOXO ONCOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2018 | Q2 2018 | 1 |
CRVL | CORVEL CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2015 | Q4 2015 | 1 |
PERNIX THERAPEUTICS HO... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2017 | Q1 2017 | 1 | |
NABRIVA THERAPEUTICS PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2017 | Q3 2017 | 1 | |
AMED | AMEDISYS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2018 | Q4 2018 | 1 |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 |
HZNP | HORIZON PHARMA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2014 | Q1 2014 | 1 |
STAA | STAAR SURGICAL CO | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2018 | Q4 2018 | 1 |
BKD | BROOKDALE SR LIVING INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 |
LMAT | LEMAITRE VASCULAR INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q2 2015 | 1 |
ALLK | ALLAKOS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q3 2019 | 1 |
MEDP | MEDPACE HLDGS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q3 2019 | 1 |
ITOS | ITEOS THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q4 2021 | 1 |
BLFS | BIOLIFE SOLUTIONS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2018 | Q3 2018 | 1 |
SSH | SUNSHINE HEART INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2014 | Q2 2014 | 1 |
LUMINEX CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q1 2020 | 1 | |
MOH | MOLINA HEALTHCARE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2017 | Q3 2017 | 1 |
NK | NANTKWEST INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2015 | Q4 2015 | 1 |
FVE | FIVE STAR QUALITY CARE | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2016 | Q4 2016 | 1 |
GNVC | GENVEC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2016 | Q4 2016 | 1 |
GH | GUARDANT HEALTH INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q2 2019 | 1 |
PRSC | PROVIDENCE SVC CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2014 | Q3 2014 | 1 |
SIBN | SI-BONE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2018 | Q4 2018 | 1 |
AZN | ASTRAZENECA PLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2013 | Q3 2013 | 1 |
REPH | RECRO PHARMA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2015 | Q3 2015 | 1 |
ARQULE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q3 2019 | 1 | |
MTD | METTLER TOLEDO INTERNA... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2016 | Q3 2016 | 1 |
ARAY | ACCURAY INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2016 | Q3 2016 | 1 |
ICPT | INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2017 | Q3 2017 | 1 |
BEAT | BIOTELEMETRY INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 |
AMRI | ALBANY MOLECULAR RESEARCH | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2016 | Q3 2016 | 1 |
NEOT | NEOTHETICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q2 2015 | 1 |
GI | ENDOCHOICE HLDGS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2016 | Q1 2016 | 1 |
OPTN | OPTINOSE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2019 | Q4 2019 | 1 |
EVH | EVOLENT HEALTH INC SHA... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2017 | Q1 2017 | 1 |
LMNX | LUMINEX CORP DEL | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2020 | Q2 2020 | 1 |
CONFORMIS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q2 2019 | 1 | |
KYTH | KYTHERA BIOPHARMACEUTI... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2013 | Q3 2013 | 1 |
ABCL | ABCELLERA BIOLOGICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
AAVL | AVALANCHE BIOTECHNOLOG... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2016 | Q1 2016 | 1 |
PSNL | PERSONALIS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
CVET | COVETRUS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
REGN | REGENERON PHARMACEUTICALS | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2018 | Q1 2018 | 1 |
TKNO | ALPHA TEKNOVA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 |
ARAV | ARAVIVE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2019 | Q4 2019 | 1 |
AFFX | AFFYMETRIX INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2013 | Q4 2013 | 1 |
MDGWW | AEVI GENOMIC MEDICINE ... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2016 | Q4 2016 | 1 |
VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 |
UTMD | UTAH MED PRODS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2015 | Q4 2015 | 1 |
ABBOTT LABS | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2016 | Q2 2016 | 1 | |
AIQ | ALLIANCE HEALTHCARE ... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2014 | Q3 2014 | 1 |
IPOF | SOCIAL CAPITAL HEDOSOP... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
ACETQ | ACETO CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2016 | Q3 2016 | 1 |
REPL | REPLIMUNE GROUP INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
CVM | CEL-SCI CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
CNST | CONSTELLATION PHARMCET... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2019 | Q4 2019 | 1 |
TARA | ARTARA THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q1 2020 | 1 |
NAVB | NAVIDEA BIOPHARMACEUTI... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q2 2013 | 1 |
AIMT | AIMMUNE THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2016 | Q2 2016 | 1 |
AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 |
OHRP | OHR PHARMACEUTICAL INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q4 2014 | 1 |
PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2018 | Q1 2018 | 1 |
ATARA BIOTHERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q2 2016 | 1 | |
CORT | CORCEPT THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q2 2016 | 1 |
SPY | SPDR S&P 500 ETF TR | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2020 | Q1 2020 | 1 |
CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 |
SANA | SANA BIOTECHNOLOGY INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q1 2021 | 1 |
RCM | R1 RCM SHARES | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q1 2017 | 1 |
JUNO | JUNO THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2017 | Q4 2017 | 1 |
CFMS | CONFORMIS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2019 | Q3 2019 | 1 |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2017 | Q3 2017 | 1 |
OPHT | OPHTHOTECH CORP PUT 2... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
BTX | BIOTIME INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q2 2016 | 1 |
DGX | QUEST DIAGNOSTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2013 | Q2 2013 | 1 |
APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2023 | Q3 2023 | 1 |
HMA | HEALTH MGMT ASSOC INC NEW | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2013 | Q2 2013 | 1 |
SGEN | SEATTLE GENETICS INC /WA | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q4 2014 | 1 |
ELOX | ELLOX PHARMACEUTICALS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2018 | Q2 2018 | 1 |
VRX | VALEANT PHARMACEUTICAL... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
RAPT | RAPT THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q2 2021 | 1 |
AXDX | ACCELERATE DIAGNOSTICS... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q4 2015 | 1 |
IONS | IONIS PHARMACEUTICALS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2017 | Q3 2017 | 1 |
ASND | ASCENDIS PHARMA A S | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
ACHC | ACADIA HEALTHCARE COMP... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q1 2017 | 1 |
DVAX | DYNAVAX TECHNOLOGIES C... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
GERN | GERON CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q3 2018 | 1 |
DIA | SPDR DOW JONES INDUSTR... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
XOMA | XOMA LTD | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q4 2014 | 1 |
XBI | SPDR SandP BIOTECH ETF | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
XBI | STREETTRACKS SPDR BIOT... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
GLD | SPDR GOLD SHARES ETF | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
BTAI | BIOXCEL THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2023 | Q2 2023 | 1 |
IMGN | IMMUNOGEN INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 |
CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
JNJ | JOHNSON and JOHNSON | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
BRKR | BRUKER | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
TMO | THERMO FISHER SCIENTIFIC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
OBLN | OBALON THERAPEUTICS S... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q1 2017 | 1 |
CERS | CERUS SHARES | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q1 2017 | 1 |
ZTS | ZOETIS CLASS A | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2016 | 1 |
MNKD | MANNKIND CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q1 2015 | 1 |
Download |
The securities at the top of the list , including NEUROCRINE BIOSCIENCES SHARES, AMICUS THERAPEUTICS SHARES, and ALDEYRA THERAPEUTICS SHARES, are the highest-conviction holdings of Perceptive Advisors.
The conviction is calculated by counting the number of quarters a security has been reported by Perceptive Advisors. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Perceptive Advisors owns currently or has owned in the past.